projects

Commission Directive 2009/2/EC of 15 January 2009 amending, for the purpose of its adaptation to technical progress, for the 31st time, Council Directive 67/548/EEC on the approximation of the laws, regulations and administrative provisions relating to the classification, packaging and labelling of dangerous substances (Text with EEA relevance)

32009L0002DirectiveFeb 5, 2009

Open source

of 15 January 2009

amending, for the purpose of its adaptation to technical progress, for the 31st time, Council Directive 67/548/EEC on the approximation of the laws, regulations and administrative provisions relating to the classification, packaging and labelling of dangerous substances

(Text with EEA relevance)

Preamble

THE COMMISSION OF THE EUROPEAN COMMUNITIES,

Having regard to the Treaty establishing the European Community,

Having regard to Council Directive 67/548/EEC of 27 June 1967 on the approximation of the laws, regulations and administrative provisions relating to the classification, packaging and labelling of dangerous substances 1 , and in particular Article 28 thereof,

Whereas:

(1) Article 4(3) of Directive 67/548/EEC sets out the criteria and the procedure to be followed to harmonise the classification and labelling of substances. Paragraphs 4.1.3, 4.1.4 and 4.1.5 of Annex VI to Directive 67/548/EEC oblige industry to provide information to Member States and Member States to make proposals for harmonised classification and labelling as a matter of urgency, when information becomes available justifying that a substance fulfils the criteria as a mutagenic, carcinogenic or reproductive toxic chemical.

(2) Annex I to Directive 67/548/EEC contains a list of dangerous substances, together with particulars of the classification and labelling of each substance. That list needs to be updated to include further notified new substances and further existing substances, as well as to adapt certain entries to technical progress. In addition, it is necessary, in that Annex, to delete entries for certain substances.

(3) Annex I to Directive 67/548/EEC already contains numerous group entries in particular for metal compounds evaluated using a grouping and read across approach based on analogy between substances.

(4) Annex I to Directive 67/548/EEC also contains certain groups where members of the group are identified and where the classification was derived by applying grouping and read across approaches, notably the petroleum streams and gasses.

(5) Annex VI to Directive 67/548/EEC states that the data required for classification and labelling may be obtained from a number of different sources, including the results of validated structure-activity relationships and expert judgement.

(6) The classifications of the nickel compounds listed in this Directive are based on the effects originating from the Ni(2+) ion and on the available data for nickel compounds. The classifications were derived by grouping nickel compounds into categories on the basis of water solubility (e.g. groups insoluble, slightly soluble and soluble nickel compounds respectively). Water solubility was used as an initial criterion to define these categories, based on the argument that nickel substances having similar water solubility will indicate similar bioavailability of the Ni(2+) ion and similar systemic toxicity. This justifies a read across within groups from the substances for which the available adequate test data demonstrate a specific systemic effect to those lacking such test data. For some effects, read across between groups is justified, as similar effects have been observed across the range of water solubility. For example, epidemiological studies show that both soluble and insoluble nickel compounds (at opposite ends of the range of solubility) have local carcinogenic effects in the respiratory tract. There is, therefore, good reason to conclude that slightly soluble compounds (at the middle of this range) have similar carcinogenic properties.

(7) As part of an evaluation of all the available information for the nickel compounds, water solubility can be used as an approximation of systemic bioavailability of the Ni(2+) ion for many effects and substances.

(8) The classification and labelling of the substances listed in this Directive should be reviewed if new scientific knowledge becomes available. In this context, noting in particular that the nickel industry has recently submitted preliminary, partial and not peer-reviewed information, special attention should be paid to the outcome of future discussions within the World Health Organisation's International Agency for Research on Cancer on the carcinogenicity of nickel substances, or to any relevant new scientific findings or interpretations of the data used to establish the classifications for the nickel compounds included in this Directive.

(9) The measures provided for in this Directive are in accordance with the opinion of the Committee on the Adaptation to Technical Progress of the Directives for the Elimination of Technical Barriers to Trade with Dangerous Substances and Preparations,

HAS ADOPTED THIS DIRECTIVE:

Article 1

Directive 67/548/EEC is amended as follows. Annex I is amended as follows:

(a) the entries corresponding to the entries set out in Annex 1A to this Directive are replaced by the entries set out in that Annex;

(b) the entries set out in Annex 1B to this Directive are inserted in accordance with the order of the entries set out in Annex I to Directive 67/548/EEC;

(c) the entries set out in Annex 1C to this Directive are deleted.

Article 2

Member States shall bring into force the laws, regulations and administrative provisions necessary to comply with this Directive by 1 June 2009 at the latest. They shall forthwith communicate to the Commission the text of those provisions and a correlation table between those provisions and this Directive.

When Member States adopt those provisions, they shall contain a reference to this Directive or be accompanied by such a reference on the occasion of their official publication. Member States shall determine how such reference is to be made.

Member States shall communicate to the Commission the text of the main provisions of national law which they adopt in the field covered by this Directive.

Article 3

This Directive shall enter into force on the twentieth day following that of its publication in the Official Journal of the European Union .

Article 4

This Directive is addressed to the Member States.

Final provisions

Done at Brussels, 15 January 2009. For the Commission Stavros DIMAS Member of the Commission

1 OJ 196, 16.8.1967, p. 1 .

Index NoChemical nameNotes related to substancesEC NoCAS NoClassificationLabellingConcentration LimitsNotes related to preparations
001-002-00-4aluminium lithium hydride240-877-916853-85-3F; R15
C; R35		F; C
R: 15-35
S: (1/2-)7/8-26-36/37/39-43-45
005-006-00-7dibutyltin hydrogen borateE401-040-575113-37-0Muta. Cat. 3; R68
Repr. Cat. 2; R60-61
T; R48/25
Xn; R21/22
Xi; R41
R43
N; R50-53		T; N
R: 60-61-21/22-41-43-48/25-68-50/53
S: 53-45-60-61
006-007-00-5salts of hydrogen cyanide with the exception of complex cyanides such as ferrocyanides, ferricyanides and mercuric oxycyanide and those specified elsewhere in this AnnexA——T+; R26/27/28
R32
N; R50-53		T+; N
R: 26/27/28-32-50/53
S: (1/2-)7-28-29-45-60-61
006-015-00-9diuron (ISO);
3-(3,4-dichlorophenyl)-1,1-dimethylurea		206-354-4330-54-1Carc. Cat. 3; R40
Xn; R22-48/22
N; R50-53		Xn; N
R: 22-40-48/22-50/53
S: (2-)13-36/37-46-60-61		C ≥ 25 %: Xn, N; R22-40-48/22-50/53
10 % ≤ C < 25 %: Xn, N; R40-48/22-50/53
2,5 % ≤ C < 10 %: Xn, N; R40-50/53
1 % ≤ C < 2,5 %: Xn, N; R40-51/53
0,25 % ≤ C < 1 %: N; R51/53
0,025 % ≤ C < 0,25 %: R52/53
006-076-00-1mancozeb (ISO);
manganese ethylenebis(dithiocarbamate) (polymeric) complex with zinc salt		—8018-01-7Repr. Cat. 3; R63
R43
N; R50		Xn; N
R: 43-63-50
S: (2-)36/37-46-61		C ≥ 5 %: Xn, N; R43-63-50
2,5 ≤ C < 5 %: Xi, N; R43-50
1 % ≤ C < 2,5 %: Xi; R43
006-077-00-7maneb (ISO);
manganese ethylenebis(dithiocarbamate) (polymeric)		235-654-812427-38-2Repr. Cat. 3; R63
Xn; R20
Xi; R36
R43
N; R50-53		Xn; N
R: 20-36-43-63-50/53
S: (2-)36/37-46-60-61		C ≥ 25 %: Xn, N; R20-36-43-63-50/53
20 % ≤ C < 25 %: Xn, N; R36-43-63-50/53
5 % ≤ C < 20 %: Xn, N; R43-63-50/53
2,5 % ≤ C < 5 %: Xi, N; R43-50/53
1 % ≤ C < 2,5 %: Xi, N; R43-51/53
0,25 % ≤ C < 1 %: N; R51/53
0,025 % ≤ C < 0,25 %: R52/53
006-084-00-5carbosulfan (ISO);
2,3-dihydro-2,2-dimethyl-7-benzofuryl [(dibutylamino)thio]methylcarbamate		259-565-955285-14-8T+; R26
T; R25
R43
N; R50-53		T+; N
R: 25-26-43-50/53
S: (1/2-)28-36/37-38-45-63-60-61
006-088-00-7benfuracarb (ISO);
ethyl N -[2,3-dihydro-2,2-dimethylbenzofuran-7-yloxycarbonyl(methyl)aminothio]- N -isopropyl-β-alaninate		—82560-54-1Repr. Cat. 3; R62
T; R23
Xn; R22
N; R50-53		T; N
R: 22-23-62-50/53
S: (1/2-)36/37-45-60-61
007-002-00-0nitrogen dioxide; [1]
dinitrogen tetraoxide [2]		233-272-6 [1]
234-126-4 [2]		10102-44-0 [1]
10544-72-6 [2]		O; R8
T+; R26
C; R34		O; T+
R: 8-26-34
S: (1/2-)9-26-28-36/37/39-45		C ≥ 10 %: T+; R26-34
5 % ≤ C < 10 %: T; R23-34
1 % ≤ C < 5 %: T; R23-36/37/38
0,5 % ≤ C < 1 %: Xn; R20-36/37/38
0,1 % ≤ C < 0,5 %: Xn; R20		5
015-041-00-Xmalathion (ISO);
1,2-bis(ethoxycarbonyl)ethyl O,O -dimethyl phosphorodithioate;
[containing ≤ 0,03 % isomalathion]		204-497-7121-75-5Xn; R22
R43
N; R50-53		Xn; N
R: 22-43-50/53
S: (2-)24-37-46-60-61		C ≥ 25 %: Xn, N; R22-43-50/53
1 % ≤ C < 25 %: Xi, N; R43-50/53
0,025 % ≤ C < 1 %: N; R50/53
0,0025 % ≤ C < 0,025 %: N; R51/53
0,00025 % ≤ C < 0,0025 %: R52/53
015-100-00-Xphoxim (ISO);
α-(diethoxyphosphinothioylimino) phenylacetonitrile		238-887-314816-18-3Repr. Cat. 3; R62
Xn; R22
R43
N; R50-53		Xn; N
R: 22-43-62-50/53
S: (2-)36/37-46-60-61		C ≥ 25 %: Xn, N; R22-43-62-50/53
5 % ≤ C < 25 %: Xn, N; R43-62-50/53
1 % ≤ C < 5 %: Xi, N; R43-50/53
0,025 % ≤ C < 1 %: N; R50/53
0,0025 % ≤ C < 0,025 %: N; R51/53
0,00025 % ≤ C < 0,0025 %: R52/53
015-102-00-0tris(2-chloroethyl)phosphateE204-118-5115-96-8Carc. Cat. 3; R40
Repr. Cat. 2; R60
Xn; R22
N; R51-53		T; N
R: 60-22-40-51/53
S: 53-45-61
015-155-00-Xglufosinate ammonium (ISO);
ammonium 2-amino-4-(hydroxymethylphosphinyl)butyrate		E278-636-577182-82-2Repr. Cat. 2; R60
Repr. Cat. 3; R63
Xn; R20/21/22-48/20/22		T
R: 60-20/21/22-48/20/22-63
S: 53-45
016-009-00-8disodium sulfide;
sodium sulfide		215-211-51313-82-2T; R24
Xn; R22
C; R34
R31
N; R50		T; C; N
R: 22-24-31-34-50
S: (1/2-)26-36/37/39-45-61
017-009-00-0ammonium perchlorate;
[containing ≥ 80 % of 0-30 μm particles]		T232-235-17790-98-9E; R3
O; R9		E
R: 3-9
S: (2-)14-16-36/37
024-004-00-7sodium dichromateE234-190-310588-01-9O; R8
Carc. Cat. 2; R45
Muta. Cat. 2; R46
Repr. Cat. 2; R60-61
T+; R26
T; R25-48/23
Xn; R21
C; R34
R42/43
N; R50-53		O; T+; N
R: 45-46-60-61-8-21-25-26-34-42/43-48/23-50/53
S: 53-45-60-61		C ≥ 25 %: T+, N; R45-46-60-61-21-25-26-34-42/43-48/23-50/53
10 % ≤ C < 25 %: T+, N; R45-46-60-61-22-26-34-42/43-48/23-51/53
7 % ≤ C < 10 %: T+, N; R45-46-60-61-22-26-36/37/38-42/43-48/20-51/53
5 % ≤ C < 7 %: T, N; R45-46-60-61-22-23-36/37/38-42/43-48/20-51/53
3 % ≤ C < 5 %: T, N; R45-46-60-61-22-23-42/43-48/20-51/53
2,5 % ≤ C < 3 %: T, N; R45-46-60-61-23-42/43-48/20-51/53
1 % ≤ C < 2,5 %: T; R45-46-60-61-23-42/43-48/20-52/53
0,5 % ≤ C < 1 %: T; R45-46-60-61-20-42/43-52/53
0,25 % ≤ C < 0,5 %: T; R45-46-20-42/43-52/53
0,2 % ≤ C < 0,25 %: T; R45-46-20-42/43
0,1 % ≤ C < 0,2 %: T; R45-46-20		3
027-002-00-4cobalt oxide215-154-61307-96-6Xn; R22
R43
N; R50-53		Xn; N
R: 22-43-50/53
S: (2-)24-37-60-61		C ≥ 25 %: Xn, N; R22-43-50/53
2,5 % ≤ C < 25 %: Xi, N; R43-50/53
1 % ≤ C < 2,5 %: Xi, N; R43-51/53
0,25 % ≤ C < 1 %: N; R51/53
0,025 % ≤ C < 0,25 %: R52/53
027-003-00-Xcobalt sulfide215-273-31317-42-6R43
N; R50-53		Xi; N
R: 43-50/53
S: (2-)24-37-60-61		C ≥ 2,5 %: Xi, N; R43-50/53
1 % ≤ C < 2,5 %: Xi, N; R43-51/53
0,25 % ≤ C < 1 %: N; R51/53
0,025 % ≤ C < 0,25 %: R52/53
028-003-00-2nickel monoxide; [1]
nickel oxide; [2]
bunsenite [3]		E215-215-7 [1]
234-323-5 [2]
- [3]		1313-99-1 [1]
11099-02-8 [2]
34492-97-2 [3]		Carc. Cat. 1; R49
T; R48/23
R43
R53		T
R: 49-43-48/23-53
S: 53-45-61
028-004-00-8nickel dioxideE234-823-312035-36-8Carc. Cat. 1; R49
T; R48/23
R43
R53		T
R: 49-43-48/23-53
S: 53-45-61
028-005-00-3dinickel trioxideE215-217-81314-06-3Carc. Cat. 1; R49
T; R48/23
R43
R53		T
R: 49-43-48/23-53
S: 53-45-61
028-006-00-9nickel (II) sulfide; [1]
nickel sulfide; [2]
millerite [3]		E240-841-2 [1]
234-349-7 [2]
- [3]		16812-54-7 [1]
11113-75-0 [2]
1314-04-1 [3]		Carc. Cat. 1; R49
Muta. Cat. 3; R68
T; R48/23
R43
N; R50-53		T; N
R: 49-43-48/23-68-50/53
S: 53-45-60-61
028-007-00-4trinickel disulfide;
nickel subsulfide; [1]
heazlewoodite [2]		E234-829-6 [1]
- [2]		12035-72-2 [1]
12035-71-1 [2]		Carc. Cat. 1; R49
Muta. Cat. 3; R68
T; R48/23
R43
N; R50-53		T; N
R: 49-43-48/23-68-50/53
S: 53-45-60-61
028-008-00-Xnickel dihydroxide; [1]
nickel hydroxide [2]		E235-008-5 [1]
234-348-1 [2]		12054-48-7 [1]
11113-74-9 [2]		Carc. Cat. 1; R49
Repr. Cat. 2; R61
Muta. Cat. 3; R68
T; R48/23
Xn; R20/22
Xi; R38
R42/43
N; R50-53		T; N
R: 49-61-20/22-38-42/43-48/23-68-50/53
S: 53-45-60-61
029-013-00-Xtrisodium(2-(α-(3-(4-chloro-6-(2-(2-(vinylsulfonyl)ethoxy)ethylamino)-1,3,5-triazin-2-ylamino)-2-oxido-5-sulfonatophenylazo)benzylidenehydrazino)-4-sulfonatobenzoato)copper(II)407-580-8130201-51-3Xi; R41Xi
R: 41
S: (2-)26-39
033-005-00-1arsenic acid and its salts with the exception of those specified elsewhere in this AnnexAE——Carc. Cat. 1; R45
T; R23/25
N; R50-53		T; N
R: 45-23/25-50/53
S: 53-45-60-61
034-002-00-8selenium compounds with the exception of cadmium sulphoselenide and those specified elsewhere in this AnnexA——T; R23/25
R33
N; R50-53		T; N
R: 23/25-33-50/53
S: (1/2-)20/21-28-45-60-61
047-001-00-2silver nitrate231-853-97761-88-8O; R8
C; R34
N; R50-53		O; C; N
R: 8-34-50/53
S: (1/2-)26-36/37/39-45-60-61
050-002-00-0cyhexatin (ISO);
hydroxytricyclohexylstannane;
tri(cyclohexyl)tin hydroxide		236-049-113121-70-5Xn; R20/21/22
N; R50-53		Xn; N
R: 20/21/22-50/53
S: (2-)13-60-61		C ≥ 25 %: Xn, N; R20/21/22-50/53
0,025 % ≤ C < 25 %: N; R50/53
0,0025 % ≤ C < 0,025 %: N; R51/53
0,00025 % ≤ C < 0,0025 %: R52/53
050-003-00-6fentin acetate (ISO);
triphenyltin acetate		212-984-0900-95-8Carc. Cat. 3; R40
Repr. Cat. 3; R63
T+; R26
T; R24/25-48/23
Xi; R37/38-41
N; R50-53		T+; N
R: 24/25-26-37/38-40-41-48/23-63-50/53
S: (1/2-)26-28-36/37/39-45-60-61		C ≥ 25 %: T+, N; R24/25-26-37/38-40-41-48/23-63-50/53
20 % ≤ C < 25 %: T+, N; R21/22-26-37/38-40-41-48/23-63-50/53
10 % ≤ C < 20 %: T+, N; R21/22-26-40-41-48/23-63-50/53
7 % ≤ C < 10 %: T+, N; R21/22-26-36-40-48/20-63-50/53
5 % ≤ C < 7 %: T, N; R21/22-23-36-40-48/20-63-50/53
3 % ≤ C < 5 %: T, N; R21/22-23-40-48/20-50/53
2,5 % ≤ C < 3 %: T, N; R23-40-48/20-50/53
1 % ≤ C < 2,5 %: T, N; R23-40-48/20-51/53
0,25 % ≤ C < 1 %: Xn, N; R20-51/53
0,1 % ≤ C < 0,25 %: Xn; R20-52/53
0,025 % ≤ C < 0,1 %: R52/53
050-004-00-1fentin hydroxide (ISO);
triphenyltin hydroxide		200-990-676-87-9Carc. Cat. 3; R40
Repr. Cat. 3; R63
T+; R26
T; R24/25-48/23
Xi; R37/38-41
N; R50-53		T+; N
R: 24/25-26-37/38-40-41-48/23-63-50/53
S: (1/2-)26-28-36/37/39-45-60-61		C ≥ 25 %: T+, N; R24/25-26-37/38-40-41-48/23-63-50/53
20 % ≤ C < 25 %: T+, N; R21/22-26-37/38-40-41-48/23-63-50/53
10 % ≤ C < 20 %: T+, N; R21/22-26-40-41-48/23-63-50/53
7 % ≤ C < 10 %: T+, N; R21/22-26-36-40-48/20-63-50/53
5 % ≤ C < 7 %: T, N; R21/22-23-36-40-48/20-63-50/53
3 % ≤ C < 5 %: T, N; R21/22-23-40-48/20-50/53
2,5 % ≤ C < 3 %: T, N; R23-40-48/20-50/53
1 % ≤ C < 2,5 %: T, N; R23-40-48/20-51/53
0,25 % ≤ C < 1 %: Xn, N; R20-51/53
0,1 % ≤ C < 0,25 %: Xn; R20-52/53
0,025 % ≤ C < 0,1 %: R52/53
050-008-00-3tributyltin compounds, with the exception of those specified elsewhere in this AnnexA——T; R25-48/23/25
Xn; R21
Xi; R36/38
N; R50-53		T; N
R: 21-25-36/38-48/23/25-50/53
S: (1/2-)36/37/39-45-60-61		C ≥ 2,5 %: T, N; R21-25-36/38-48/23/25-50/53
1 % ≤ C < 2,5 %: T, N; R21-25-36/38-48/23/25-51/53
0,25 % ≤ C < 1 %: Xn, N; R22-48/20/22-51/53
0,025 % C < 0,25 %: R52/53		1
050-011-00-Xtriphenyltin compounds, with the exception of those specified elsewhere in this AnnexA——T; R23/24/25
N; R50-53		T; N
R: 23/24/25-50/53
S: (1/2-)26-27-28-45-60-61		C ≥ 1 %: T, N; R23/24/25-50/53
0,25 % ≤ C < 1 %: Xn, N; R20/21/22-50/53
0,025 % ≤ C < 0,25 %: N; R51/53
0,0025 % ≤ C < 0,025 %: R52/53		1
050-018-00-8tin(II) methanesulphonate401-640-753408-94-9C; R34
Xn; R22
R43
N; R51-53		C; N
R: 22-34-43-51/53
S: (1/2-)22-26-36/37/39-45-61
053-003-00-4iodoxybenzene—696-33-3E; R2E
R: 2
S: (2-)35
053-004-00-Xcalcium iodoxybenzoateC——E; R2E
R: 2
S: (2-)35
080-001-00-0mercuryE231-106-77439-97-6Repr. Cat. 2; R61
T+; R26
T; R48/23
N; R50-53		T+; N
R: 61-26-48/23-50/53
S: 53-45-60-61
080-010-00-Xmercury dichloride;
mercuric chloride		231-299-87487-94-7Muta. Cat. 3; R68
Repr. Cat. 3; R62
T+; R28
T; R48/24/25
C; R34
N; R50-53		T+; N
R: 28-34-48/24/25-62-68-50/53
S: (1/2-)26-36/37/39-45-60-61
092-002-00-3uranium compounds with the exception of those specified elsewhere in this AnnexA——T+; R26/28
R33
N; R51-53		T+; N
R: 26/28-33-51/53
S: (1/2-)20/21-45-61
601-065-00-3A mixture of: (1′α,3′α,6′α)-2,2,3′,7′,7′-pentamethylspiro(1,3-dioxane-5,2′-norcarane);
(1′α,3′β,6′α)-2,2,3′,7′,7′-pentamethylspiro(1,3-dioxane-5,2′-norcarane)		416-930-9—Xi; R38
N; R51-53		Xi; N
R: 38-51/53
S: (2-)36/37-61
602-007-00-Xbromoform;
tribromomethane		200-854-675-25-2T; R23
Xn; R22
Xi; R36/38
N; R51-53		T; N
R: 22-23-36/38-51/53
S: (1/2-)28-45-63-61
602-030-00-51,3-dichloropropene; [1]
( Z )-1,3-dichloropropene [2]		C D208-826-5 [1]
233-195-8 [2]		542-75-6 [1]
10061-01-5 [2]		R10
T; R24/25
Xn; R20-65
Xi; R36/37/38
R43
N; R50-53		T; N
R: 10-20-24/25-36/37/38-43-65-50/53
S: (1/2-)36/37-45-60-61
602-054-00-63-iodpropene;
allyl iodide		209-130-4556-56-9F; R11
C; R34		F; C
R: 11-34
S: (1/2-)7-16-26-45
603-005-00-12-methylpropan-2-ol;
tert -butyl alcohol		200-889-775-65-0F; R11
Xn; R20
Xi; R36/37		F; Xn
R: 11-20-36/37
S: (2-)9-16-46
603-018-00-2furfuryl alcohol202-626-198-00-0Carc. Cat. 3; R40
T; R23
Xn; R21/22-48/20
Xi; R36/37		T
R: 21/22-23-36/37-40-48/20
S: (1/2-)36/37-45-63
603-023-00-Xethylene oxide;
oxirane		E200-849-975-21-8F+; R12
R6
Carc. Cat. 2; R45
Muta. Cat. 2; R46
T; R23
Xi; R36/37/38		F+; T
R: 45-46-6-12-23-36/37/38
S: 53-45
603-029-00-2bis(2-chloroethyl) ether203-870-1111-44-4Carc. Cat. 3; R40
T+; R26/27/28		T+
R: 26/27/28-40
S: (1/2-)7/9-27-28-36/37-45		C ≥ 7 %: T+; R26/27/28-40
1 % ≤ C < 7 %: T; R23/24/25-40
0,1 % ≤ C < 1 %: Xn; R20/21/22
603-037-00-6cellulose nitrate;
nitrocellulose		T——E; R3E
R: 3
S: (2-)35
603-046-00-5bis(chloromethyl) ether;
oxybis(chloromethane)		E208-832-8542-88-1F; R11
Carc. Cat. 1; R45
T+; R26
T; R24
Xn; R22		F; T+
R: 45-11-22-24-26
S: 53-45		C ≥ 25 %: T+; R45-22-24-26
7 % ≤ C < 25 %: T+; R45-21-26
3 % ≤ C < 7 %: T; R45-21-23
1 % ≤ C < 3 %: T; R45-23
0,1 % ≤ C < 1 %: T; R45-20
0,001 % ≤ C < 0,1 %: T; R45
603-064-00-31-methoxy-2-propanol;
monopropylene glycol methyl ether		203-539-1107-98-2R10
R67		R: 10-67
S: (2-)
603-066-00-41,2-epoxy-4-epoxyethylcyclohexane;
4-vinylcyclohexene diepoxide		203-437-7106-87-6Carc. Cat. 3; R40
T; R23/24/25		T
R: 23/24/25-40
S: (1/2-)36/37-45-63		C ≥ 1 %: T; R23/24/25-40
0,1 % ≤ C < 1 %: Xn; R20/21/22
605-004-00-12,4,6-trimethyl-1,3,5-trioxane;
paraldehyde		204-639-8123-63-7R10R: 10
S: (2-)29
605-005-00-72,4,6,8-tetramethyl-1,3,5,7-tetraoxacyclooctane;
metaldehyde		203-600-2108-62-3F; R11
Xn; R22		F; Xn
R: 11-22
S: (2-)13-16-25-46
606-021-00-7N -methyl-2-pyrrolidone;
1-methyl-2-pyrrolidone		212-828-1872-50-4Repr. Cat. 2; R61
Xi; R36/37/38		T
R: 61-36/37/38
S: 53-45		C ≥ 10 %: T; R61-36/37/38
5 % ≤ C < 10 %: T; R61
607-007-00-3salts of oxalic acid with the exception of those specified elsewhere in this AnnexA——Xn; R21/22Xn
R: 21/22
S: (2-)24/25		C ≥ 5 %: Xn; R21/22
607-012-00-0benzoyl chloride202-710-898-88-4Xn; R20/21/22
C; R34
R43		C
R: 20/21/22-34-43
S: (1/2-)26-36/37/39-45
607-037-00-72-ethoxyethyl acetate;
ethylglycol acetate		E203-839-2111-15-9R10
Repr. Cat. 2; R60-61
Xn; R20/21/22		T
R: 60-61-10-20/21/22
S: 53-45
607-051-00-3MCPA (ISO);
4-chloro- o -tolyloxyacetic acid		202-360-694-74-6Xn; R22
Xi; R38-41
N; R50-53		Xn; N
R: 22-38-41-50/53
S: (2-)26-37-39-60-61
607-052-00-9salts and esters of MCPAA——Xn; R20/21/22
N; R50-53		Xn; N
R: 20/21/22-50/53
S: (2-)13-60-61
607-085-00-9benzyl benzoate204-402-9120-51-4Xn; R22
N; R51-53		Xn; N
R: 22-51/53
S: (2-)25-46-61
607-095-00-3maleic acid203-742-5110-16-7Xn; R22
Xi; R36/37/38
R43		Xn
R: 22-36/37/38-43
S: (2-)24-26-28-37-46		C ≥ 25 %: Xn; R22-36/37/38-43
20 % ≤ C <25 %: Xi; R36/37/38-43
0,1 % ≤ C < 20 %: Xi; R43
607-103-00-5succinic anhydride203-570-0108-30-5Xn; R22
Xi; R36/37		Xn
R: 22-36/37
S: (2-)25-46		C ≥ 5 %: Xn; R22-36/37
1 % ≤ C < 5 %: Xi; R36/37
607-142-00-8propyl chloroformate;
chloroformic acid propylester;
n -propyl chloroformate		203-687-7109-61-5F; R11
T; R23
C; R34		F; T
R: 11-23-34
S: (1/2-)16-26-36-45
607-195-00-72-methoxy-1-methylethyl acetate203-603-9108-65-6R10R: 10
S: (2-)
607-216-00-Xglutamic acid, reaction products with N -(C 12-14 -alkyl)propylenediamine403-950-8—T+; R26
Xn; R22
C; R34
N; R50		T+; N
R: 22-26-34-50
S: (1/2-)26-36/37/39-38-45-61
607-231-00-1clopyralid (ISO);
3,6-dichloropyridine-2-carboxylic acid		216-935-41702-17-6Xi; R41Xi
R: 41
S: (2-)26-39
607-245-00-8tert -butyl acrylateD216-768-71663-39-4F; R11
Xn; R20/21/22
Xi; R37/38
R43
N; R51-53		F; Xn; N
R: 11-20/21/22-37/38-43-51/53
S: (2-)16-25-37-61		C ≥ 25 %: Xn; R20/21/22-37/38-43-51/53
20 % ≤ C < 25 %: Xi; R37/38-43-52/53
2,5 % ≤ C < 20 %: Xi; R43-52/53
1 % ≤ C < 2,5 %: Xi; R43
607-397-00-5A mixture of: Ca salicylates (branched C 10-14 and C 18-30 alkylated);
Ca phenates (branched C 10-14 and C 18-30 alkylated);
Ca sulfurised phenates (branched C 10-14 and C 18-30 alkylated)		415-930-6—Repr. Cat. 3; R62
R43		Xn
R: 43-62
S: (2-)23-36/37
608-005-00-5n -butyronitrile203-700-6109-74-0F; R11
T; R23/24/25		F; T
R: 11-23/24/25
S: (1/2-)16-36/37-45-63
608-011-00-8oxalonitrile;
cyanogen		207-306-5460-19-5F+; R12
T; R23
N; R50-53		F+; T; N
R: 12-23-50/53
S: (1/2-)9-16-23-33-45-63-60-61
608-044-00-82-cyclohexylidene-2-phenylacetonitrile423-740-110461-98-0Xn; R22
N; R51-53		Xn; N
R; 22-51/53
S: (2-)46-61
609-007-00-92,4-dinitrotoluene; [1]
dinitrotoluene [2]		E204-450-0 [1]
246-836-1 [2]		121-14-2 [1]
25321-14-6 [2]		Carc. Cat. 2; R45
Muta. Cat. 3; R68
Repr. Cat. 3; R62
T; R23/24/25
Xn; R48/22
N; R50-53		T; N
R: 45-23/24/25-48/22-62-68-50/53
S: 53-45-60-61
611-028-00-3C,C ′-azodi(formamide)204-650-8123-77-3E; R2
R42		E; Xn
R: 2-42
S: (2-)22-24-37
611-035-00-1tetralithium 6-amino-4-hydroxy-3-[7-sulfonato-4-(5-sulfonato-2-naphthylazo)-1-naphthylazo]naphthalene-2,7-disulfonate403-660-1107246-80-0N; R51-53N
R: 51/53
S: 61
612-044-00-3N,N ′-diacetylbenzidineE210-338-2613-35-4Carc. Cat. 2; R45
Muta. Cat. 3; R68
Xn; R20/21/22		T
R: 45-20/21/22-68
S: 53-45
612-050-00-6cyclohexylamine203-629-0108-91-8R10
Repr. Cat. 3; R62
Xn; R21/22
C; R34		C
R: 10-21/22-34-62
S: (1/2-)26-36/37/39-45		C ≥ 25 %: C; R21/22-34-62
10 % ≤ C < 25 %: C; R34-62
5 % ≤ C < 10 %: Xn; R36/38-62
2 % ≤ C < 5 %: Xi; R36/38
612-076-00-8ethyldimethylamine209-940-8598-56-1F; R11
Xn; R20/22
C; R34		F; C
R: 11-20/22-34
S: (1/2-)3-16-26-36-45
612-099-00-34-methyl- m -phenylenediamine;
2,4-toluenediamine		E202-453-195-80-7Carc. Cat. 2; R45
Muta. Cat. 3; R68
Repr. Cat. 3; R62
T; R25
Xn; R21-48/22
R43
N; R51-53		T; N
R: 45-21-25-43-48/22-62-68-51/53
S: 53-45-61
612-101-00-2methenamine;
hexamethylenetetramine		202-905-8100-97-0F; R11
R43		F; Xi
R: 11-43
S: (2-)24-37
612-151-00-5methyl-phenylene diamine;
diaminotoluene;
[technical product - mixture of 4-methyl- m -phenylene diamine (EC No 202-453-1) and 2-methyl- m -phenylene diamine (EC No 212-513-9)]		E——Carc. Cat. 2; R45
Muta. Cat. 3; R68
Repr. Cat. 3; R62
T; R25
Xn; R21-48/22
Xi; R36
R43
N; R51-53		T; N
R: 45-21-25-36-43-48/22-62-68-51/53
S: 53-45-61
612-237-00-2hydroxylammonium hydrogensulfate;
hydroxylamine sulfate(1:1); [1]
hydroxylamine phosphate; [2]
hydroxylamine dihydrogenphosphate; [3]
hydroxylamine 4-methylbenzenesulfonate [4]		T233-154-4 [1]
244-077-0 [2]
242-818-2 [3]
258-872-5 [4]		10046-00-1 [1]
20845-01-6 [2]
19098-16-9 [3]
53933-48-5 [4]		E; R2
Carc. Cat. 3; R40
Xn; R21/22-48/22
Xi; R36/38
R43
N; R50		E; Xn; N
R: 21/22-36/38-40-43-48/22-50
S: (2-)36/37-61
613-116-00-7tolylfluanid (ISO);
dichloro- N -[(dimethylamino)sulphonyl]fluoro- N -( p -tolyl)methanesulphenamide;
[containing ≥ 0,1 % (w/w) of particles with an aerodynamic diameter of below 50 μm]		211-986-9731-27-1T+; R26
T; R48/23
Xi; R36/37/38
R43
N; R50		T+; N
R: 26-36/37/38-43-48/23-50
S: (1/2-)28-36/37/39-45-63-61		C ≥ 20 %: T+, N; R26-36/37/38-43-48/23-50
10 % ≤ C < 20 %: T+, N; R26-43-48/23-50
7 % ≤ C < 10 %: T+, N; R26-43-48/20-50
2,5 % ≤ C < 7 %: T, N; R23-43-48/20-50
1 % ≤ C < 2,5 %: T; R23-43-48/20
0,1 % ≤ C < 1 %: Xn; R20
615-001-00-7methyl isocyanate210-866-3624-83-9F; R11
Repr. Cat. 3; R63
T+; R26
T; R24/25
R42/43
Xi; R37/38-41		F; T+
R: 11-24/25-26-37/38-41-42/43-63
S: (1/2-)16-26-27/28-36/37/39-45-63
615-004-00-3salts of thiocyanic acid, with the exception of those specified elsewhere in this AnnexA——Xn; R20/21/22
R32
R52-53		Xn
R: 20/21/22-32-52/53
S: (2-)13-36/37-46-61
615-028-00-4ethyl 2-(isocyanatosulfonyl)benzoate410-220-277375-79-2R14
Xn; R22-48/22
Xi; R41
R42/43		Xn
R: 14-22-41-42/43-48/22
S: (2-)8-23-26-30-35-36/37/39
615-030-00-5alkali salts and alkali earth salts of thiocyanic acid, with the exception of those specified elsewhere in this AnnexA——Xn; R20/21/22
R32
R52-53		Xn
R: 20/21/22-32-52/53
S: (2-)13-36/37-46-61
615-031-00-0thallium thiocyanate222-571-73535-84-0T+; R26/28
Xn; R21
R32
R33
N; R51-53		T+; N
R: 21-26/28-32-33-51/53
S: (1/2-)13-28-36/37-45-61
615-032-00-6metal salts of thiocyanic acid, with the exception of those specified elsewhere in this AnnexA——Xn; R20/21/22
R32
N; R50-53		Xn; N
R: 20/21/22-32-50/53
S: (2-)13-36/37-46-60-61
616-124-00-9lithium bis(trifluoromethylsulfonyl)imide415-300-090076-65-6T; R24/25
Xn; R48/22
C; R34
R52-53		T
R: 24/25-34-48/22-52/53
S: (1/2-)22-26-36/37/39-45-61
617-017-00-XA mixture of: 2,2′-bis( tert -pentylperoxy)- p -diisopropylbenzene;
2,2′-bis( tert -pentylperoxy)- m -diisopropylbenzene		T412-140-332144-25-5E; R2
O; R7
R53		E
R: 2-7-53
S: (2-)3/7-14-36/37/39-61
650-016-00-2Mineral wool, with the exception of those specified elsewhere in this Annex;
[Man-made vitreous (silicate) fibres with random orientation with alkaline oxide and alkali earth oxide (Na 2 O+K 2 O+CaO+MgO+BaO) content greater than 18 % by weight]		AQR——Carc. Cat. 3; R40Xn
R: 40
S: (2-)36/37
650-017-00-8Refractory Ceramic Fibres, Special Purpose Fibres, with the exception of those specified elsewhere in this Annex;
[Man-made vitreous (silicate) fibres with random orientation with alkaline oxide and alkali earth oxide (Na 2 O+K 2 O+CaO+ MgO+BaO) content less or equal to 18 % by weight]		AR——Carc. Cat. 2; R49T
R: 49
S: 53-45
Index NoChemical nameNotes related to substancesEC NoCAS NoClassificationLabellingConcentration LimitsNotes related to preparations
003-003-00-5(2-methylpropyl)lithium;
isobutyllithium		440-620-2920-36-5F; R15-17
R14
C; R35
R67
N; R50-53		F; C; N
R: 14/15-17-35-67-50/53
S: (1/2-)6-16-26-30-33-36/37/39-43-45-60-61
005-013-00-5diethylmethoxyborane425-380-97397-46-8F; R17
Xn; R20/21/22-48/22
C; R34
R43
R53		F; C
R: 17-20/21/22-34-43-48/22-53
S: (1/2-)6-26-36/37/39-43-45-61
005-014-00-04-formylphenylboronic acid438-670-587199-17-5R43Xi
R: 43
S: (2-)24-37
005-017-00-7sodium perborate; [1]
perboric acid, sodium salt; [2]
perboric acid, sodium salt, monohydrate; [3]
sodium peroxometaborate; [4]
perboric acid (HBO(O2)), sodium salt, monohydrate; [5]
sodium peroxoborate;
[containing < 0,1 % (w/w) of particles with an aerodynamic diameter of below 50 μm]		E239-172-9 [1]
234-390-0 [2]
- [3]
231-556-4 [4]
- [5]		15120-21-5 [1]
11138-47-9 [2]
12040-72-1 [3]
7632-04-4 [4]
10332-33-9 [5]		O; R8
Repr. Cat. 2; R61
Repr. Cat. 3; R62
Xn; R22
Xi; R37-41		O; T
R: 61-8-22-37-41-62
S: 53-45		C ≥ 25 %: T; R61-22-37-41-62
22 % ≤ C < 25 %: T; R61-37-41-62
20 % ≤ C < 22 %: T; R61-36/37-62
14 % ≤ C < 20 %: T; R61-36-62
9 % ≤ C < 14 %: T; R61-62
6,5 % ≤ C < 9 %: T; R61
005-017-01-4sodium perborate; [1]
perboric acid, sodium salt; [2]
perboric acid, sodium salt, monohydrate; [3]
sodium peroxometaborate; [4]
perboric acid (HBO(O2)), sodium salt, monohydrate; [5]
sodium peroxoborate;
[containing ≥ 0,1 % (w/w) of particles with an aerodynamic diameter of below 50 μm]		E239-172-9 [1]
234-390-0 [2]
- [3]
231-556-4 [4]
- [5]		15120-21-5 [1]
11138-47-9 [2]
12040-72-1 [3]
7632-04-4 [4]
10332-33-9 [5]		O; R8
Repr. Cat. 2; R61
Repr. Cat. 3; R62
T; R23
Xn; R22
Xi; R37-41		O; T
R: 61-8-22-23-37-41-62
S: 53-45		C ≥ 25 %: T; R61-22-23-37-41-62
22 % ≤ C < 25 %: T; R61-20-37-41-62
20 % ≤ C < 22 %: T; R61-20-36/37-62
14 % ≤ C < 20 %: T; R61-20-36-62
9 % ≤ C < 14 %: T; R61-20-62
6,5 % ≤ C < 9 %: T; R61-20
3 % ≤ C < 6,5 %: Xn; R20
005-018-00-2perboric acid (H3BO2(O2)), monosodium salt trihydrate; [1]
perboric acid, sodium salt, tetrahydrate; [2]
perboric acid (HBO(O2)), sodium salt, tetrahydrate; [3]
sodium peroxoborate hexahydrate;
[containing < 0,1 % (w/w) of particles with an aerodynamic diameter of below 50 μm]		- [1]
- [2]
- [3]		13517-20-9 [1]
37244-98-7 [2]
10486-00-7 [3]		Repr. Cat. 2; R61
Repr. Cat. 3; R62
Xi; R37-41		T
R: 61-37-41-62
S: 53-45-47		C ≥ 36 %: T; R61-37-41-62
22 % ≤ C < 36 %: T; R61-36/37-62
20 % ≤ C < 22 %: T; R61-37-62
14 % ≤ C < 20 %: T; R61-62
10 % ≤ C < 14 %: T; R61
005-018-01-Xperboric acid (H3BO2(O2)), monosodium salt, trihydrate; [1]
perboric acid, sodium salt, tetrahydrate; [2]
perboric acid (HBO(O2)), sodium salt, tetrahydrate; [3]
sodium peroxoborate hexahydrate;
[containing ≥ 0,1 % (w/w) of particles with an aerodynamic diameter of below 50 μm]		E- [1]
- [2]
- [3]		13517-20-9 [1]
37244-98-7 [2]
10486-00-7 [3]		Repr. Cat. 2; R61
Repr. Cat. 3; R62
Xn; R20
Xi; R37-41		T
R: 61-20-37-41-62
S: 53-45-47		C ≥ 36 %: T; R61-20-37-41-62
25 % ≤ C < 36 %: T; R61-20-36/37-62
22 % ≤ C < 25 %: T; R61-36/37-62
20 % ≤ C < 22 %: T; R61-37-62
14 % ≤ C < 20 %: T; R61-62
10 % ≤ C < 14 %: T; R61
006-097-00-61-phenyl-3-( p -toluenesulfonyl)urea424-620-113909-63-2Xn; R22-48/22
R52-53		Xn
R: 22-48/22-52/53
S: (2-)22-36-61
006-098-00-1tert -butyl (1 R ,5 S )-3-azabicyclo[3.1.0]hex-6-ylcarbamate429-170-8134575-17-0Xn; R22-48/22
Xi; R41
R43		Xn
R: 22-41-43-48/22
S: (2-)22-26-36/37/39
006-099-00-7N -( p -toluenesulfonyl)- N′ -(3-( p -toluenesulfonyloxy)phenyl)urea;
3-({[(4-methylphenyl)sulfonyl]carbamoyl}amino)phenyl 4-methylbenzenesulfonate		432-520-2232938-43-1N; R51-53N
R: 51/53
S: 22-61
006-101-00-6mixture of: N,N″ -(methylenedi-4,1-phenylene)bis[ N′ -phenylurea];
N -(4-[[4-[[(phenylamino)carbonyl]amino]phenylmethyl]phenyl]- N′ -cyclohexylurea;
N,N″ -(methylenedi-4,1-phenylene)bis[ N′ -cyclohexylurea]		423-070-8—R53R: 53
S: 61
006-102-00-1O -hexyl- N -ethoxycarbonylthiocarbamateE432-750-3—Carc. Cat. 2; R45
Muta. Cat. 2; R46
Xn; R22-48/22
R43
N; R51-53		T; N
R: 45-46-22-43-48/22-51/53
S: 53-45-61
006-103-00-7N,N″ -(methylenedi-4,1-phenylene)bis[ N′ -octyl]urea445-760-8—Xi; R41
R42
N; R50-53		Xn; N
R: 41-42-50/53
S: (2-)22-26-39-45-60-61		C ≥10 %: Xn, N; R41-42-50/53
5 % ≤ C < 10 %: Xn, N; R36-42-50/53
1 % ≤ C < 5 %: Xn, N; R42-50/53
0,25 % ≤ C < 1 %: N; R50/53
0,025 % ≤ C < 0,25 %: N; R51/53
0,0025 ≤ C < 0,025 %: R52/53
007-029-00-8diethyldimethylammonium hydroxide419-400-595500-19-9Xn; R21/22
C; R35		C
R: 21/22-35
S: (1/2-)26-36/37/39-45
012-004-00-Xaluminium-magnesium-carbonate-hydroxide-perchlorate-hydrate422-150-1—N; R50-53N
R: 50/53
S: 60-61
014-036-00-X(4-ethoxyphenyl)(3-(4-fluoro-3-phenoxyphenyl)propyl)dimethylsilane405-020-7105024-66-6Repr.Cat.2; R60
N; R50-53		T; N
R: 60-50/53
S: 53-45-60-61		C ≥ 0,5 %: T, N; R60-50/53
0,025 % ≤ C < 0,5 %: N; R50/53
0,0025 % ≤ C < 0,025 %: N; R51/53
0,00025 % ≤ C < 0,0025 %: R52/53
014-037-00-52-butanone- O,O′,O′ ′-(phenylsilylidyne)trioxime433-360-634036-80-1Xn; R48/22
R43
R52-53		Xn
R: 43-48/22-52/53
S: (2-)36/37-61
014-038-00-0S -(3-(triethoxysilyl)propyl)octanethioate436-690-9220727-26-4R43Xi
R: 43
S: (2-)24-37
014-039-00-6(2,3-dimethylbut-2-yl)-trimethoxysilane439-360-2142877-45-0Xi; R38-41
R52-53		Xi
R: 38-41-52/53
S: (2-)26-37/39-61
014-041-00-7N,N -bis(trimethylsilyl)aminopropylmethyldiethoxysilane445-890-5201290-01-9Xn; R22
R43		Xn
R: 22-43
S: (2-)24-37
014-042-00-2mixture of: O,O′,O″,O′′′ -silanetetrayl tetrakis(4-methyl-2-pentanone oxime) (3 stereoisomers)423-010-0—Xi; R41Xi
R: 41
S: (2-)26-39
014-043-00-8reaction product of amorphous silica (50-85 %), butyl (1-methylpropyl) magnesium (3-15 %), tetraethyl orthosilicate (5-15 %) and titanium tetrachloride (5-20 %)432-200-2—F; R11
Xi; R37/38-41
R52-53		F; Xi
R: 11-37/38-41-52/53
S: (2-)6-26-36/39-61
014-044-00-33-[(4′-acetoxy-3′-methoxyphenyl) propyl]trimethoxysilane433-050-0—N; R51-53N
R: 51/53
S: 61
014-045-00-9magnesium sodium fluoride silicate442-650-1—Xn; R48/20Xn
R: 48/20
S: (2-)22-36
015-190-00-0bis(2,4-dicumylphenyl) neopentyl diphosphite;
3,9-bis[2,4-bis(1-methyl-1-phenylethyl)phenoxy]-2,4,8,10-tetraoxa-3,9-diphosphaspiro[5.5]undecane		421-920-2154862-43-8R53R: 53
S: 61
015-191-00-6dodecyldiphenyl phosphate431-760-527460-02-2Xi; R38
R52-53		Xi
R: 38-52/53
S: (2-)37-61
015-192-00-1tetrakis(2,6-dimethylphenyl)- m -phenylene biphosphate432-770-2139189-30-3R43
R53		Xi
R: 43-53
S: (2-)24-37-61
015-193-00-7triphenyl(phenylmethyl)phosphonium 1,1,2,2,3,3,4,4,4-nonafluoro- N -methyl-1-butanesulfonamide (1:1)442-960-7332350-93-3T; R25
Xi; R41
N; R50-53		T; N
R: 25-41-50/53
S: (1/2-)26-39-45-60-61
015-194-00-2tetrabutyl-phosphonium nonafluoro-butane-1-sulfonate444-440-5220689-12-3Xn; R22
R52-53		Xn
R: 22-52/53
S: (2-)61
015-195-00-8mixture of: potassium o -toluenephosphonate;
potassium m -toluenephosphonate;
potassium p -toluenephosphonate		433-860-4—Xi; R36
R43
R52-53		Xi
R: 36-43-52/53
S: (2-)24-26-37-61
015-196-00-3mixture of: dimethyl (2-(hydroxymethylcarbamoyl)ethyl)phosphonate;
diethyl (2-(hydroxymethylcarbamoyl)ethyl)phosphonate;
methyl ethyl (2-(hydroxymethylcarbamoyl)ethyl)phosphonate		435-960-3—Carc.Cat.2; R45
Muta.Cat.2; R46
R43		T
R: 45-46-43
S: 53-45
015-197-00-9bis(2,4,4-trimethylpentyl)dithiophosphonic acid420-160-9107667-02-7R10
T; R23
Xn; R22
C; R34
N; R51-53		T; N
R: 10-22-23-34-51/53
S: (1/2-)9-26-36/37/39-45-61
015-198-00-4(4-phenylbutyl)phosphinic acid420-450-586552-32-1Carc.Cat.3; R40
Xi; R41		Xn
R: 40-41
S: (2-)23-26-36/37/39
016-094-00-1sulfur231-722-67704-34-9Xi; R38Xi
R: 38
S: (2-)46
016-097-00-81-amino-2-methyl-2-propanethiol hydrochloride434-480-132047-53-3Xn; R22
C; R34
R43
R52-53		C
R: 22-34-43-52/53
S: (1/2-)22-26-36/37/39-45-61
017-009-01-8ammonium perchlorate;
[containing < 80 % of 0-30 μm particles]		T232-235-17790-98-9E; R2
O; R9		E
R: 2-9
S: (2-)14-16-36/37
022-004-00-1potassium titanium oxide (K 2 Ti 6 O 13 )432-240-012056-51-8Carc.Cat.3; R40Xn
R: 40
S: (2-)22-36/37
022-005-00-7[ N -(1,1-dimethylethyl)-1,1-dimethyl-1-[(1,2,3,4,5-η)-2,3,4,5-tetramethyl-2,4-cyclopentadien-1-yl]silanaminato(2-)-κ N ][(1,2,3,4-η)-1,3-pentadiene]-titanium419-840-8169104-71-6F; R11
C; R34
R43
R53		F; C
R: 11-34-43-53
S: (1/2-)6-9-16-26-36/37/39-45-61
028-002-01-4nickel powder;
[particle diameter < 1 mm]		231-111-47440-02-0Carc. Cat. 3; R40
T; R48/23
R43
R52-53		T
R: 40-43-48/23-52/53
S: (2-)36/37/39-45-61
028-013-00-7nickel matteE, H273-749-669012-50-6Carc. Cat. 1; R49
T; R48/23
R43
N; R50-53		T; N
R: 49-43-48/23-50/53
S: 53-45-60-61
028-014-00-2slimes and sludges, copper electrolytic refining, decopperised, nickel sulfateE295-859-392129-57-2Carc. Cat. 1; R49
Muta. Cat. 3; R68
Repr. Cat. 2; R61
T; R48/23
Xn; R20/22
Xi; R38
R42/43
N; R50-53		T; N
R: 49-61-20/22-38-42/43-48/23-68-50/53
S: 53-45-60-61		C ≥ 25 %: T, N; R49-61-20/22-38-42/43-48/23-68-50/53
20 % ≤ C < 25 %: T, N; R49-61-38-42/43-48/23-68-51/53
2,5 % ≤ C < 20 %: T, N; R49-61-42/43-48/23-68-51/53
1 % ≤ C < 2,5 %: T; R49-61-42/43-48/23-68-52/53
0,5 % ≤ C < 1 %: T; R49-61-43-48/20-52/53
0,25 % ≤ C < 0,5 %: T; R49-43-48/20-52/53
0,1 % ≤ C < 0,25 %: T; R49-43-48/20
0,01 % ≤ C < 0,1 %: Xi; R43
028-015-00-8slimes and sludges, copper electrolyte refining, decopperisedE, H305-433-194551-87-8Carc. Cat. 1; R49
Muta. Cat. 3; R68
Repr. Cat. 1; R61
Repr. Cat. 3; R62
T; R48/23
R42/43
N; R50-53		T; N
R: 49-61-42/43-48/23-62-68-50/53
S: 53-45-60-61
028-016-00-3nickel diperchlorate;
perchloric acid, nickel(II) salt		E, H237-124-113637-71-3Carc. Cat. 1; R49
Muta. Cat. 3; R68
Repr. Cat. 2; R61
T; R48/23
C; R34
R42/43
N; R50-53		T; N
R: 49-61-34-42/43-48/23-68-50/53
S: 53-45-60-61		C ≥ 25 %: T, N; R49-61-34-42/43-48/23-68-50/53
5 % ≤ C < 25 %: T, N; R49-61-34-42/43-48/23-68-51/53
2,5 % ≤ C < 5 %: T, N; R49-61-36/38-42/43-48/23-68-51/53
1 % ≤ C < 2,5 %: T; R49-61-36/38-42/43-48/23-68-52/53
0,5 % ≤ C < 1 %: T; R49-61-43-48/20-52/53
0,25 % ≤ C < 0,5 %: T; R49-43-48/20-52/53
0,1 % ≤ C < 0,25 %: T; R49-43-48/20
0,01 % ≤ C < 0,1 %: Xi; R43
028-017-00-9nickel dipotassium bis(sulfate); [1]
diammonium nickel bis(sulfate) [2]		E, H237-563-9 [1]
239-793-2 [2]		13842-46-1 [1]
15699-18-0 [2]		Carc. Cat. 1; R49
Muta. Cat. 3; R68
Repr. Cat. 2; R61
T; R48/23
Xn; R20/22
R42/43
N; R50-53		T; N
R: 49-61-20/22-42/43-48/23-68-50/53
S: 53-45-60-61		C ≥ 25 %: T, N; R49-61-20/22-42/43-48/23-68-50/53
2,5 % ≤ C < 25 %: T, N; R49-61-42/43-48/23-68-51/53
1 % ≤ C < 2,5 %: T; R49-61-42/43-48/23-68-52/53
0,5 % ≤ C < 1 %: T; R49-61-43-48/20-52/53
0,25 % ≤ C < 0,5 %: T; R49-43-48/20-52/53
0,1 % ≤ C < 0,25 %: T; R49-43-48/20
0,01 % ≤ C < 0,1 %: Xi; R43
028-018-00-4nickel bis(sulfamidate);
nickel sulfamate		E, H237-396-113770-89-3Carc. Cat. 1; R49
Muta. Cat. 3; R68
Repr. Cat. 2; R61
T; R48/23
R42/43
N; R50-53		T; N
R: 49-61-42/43-48/23-68-50/53
S: 53-45-60-61		C ≥ 25 %: T, N; R49-61-42/43-48/23-68-50/53
2,5 % ≤ C < 25 %: T, N; R49-61-42/43-48/23-68-51/53
1 % ≤ C < 2,5 %: T; R49-61-42/43-48/23-68-52/53
0,5 % ≤ C < 1 %: T; R49-61-43-48/20-52/53
0,25 % ≤ C < 0,5 %: T; R49-43-48/20-52/53
0,1 % ≤ C < 0,25 %: T; R49-43-48/20
0,01 % ≤ C < 0,1 %: Xi; R43
028-019-00-Xnickel bis(tetrafluoroborate)E, H238-753-414708-14-6Carc. Cat. 1; R49
Muta. Cat. 3; R68
Repr. Cat. 2; R61
T; R48/23
R42/43
N; R50-53		T; N
R: 49-61-42/43-48/23-68-50/53
S: 53-45-60-61		C ≥ 25 %: T, N; R49-61-42/43-48/23-68-50/53
2,5 % ≤ C < 25 %: T, N; R49-61-42/43-48/23-68-51/53
1 % ≤ C < 2,5 %: T; R49-61-42/43-48/23-68-52/53
0,5 % ≤ C < 1 %: T; 49-61-43-48/20-52/53
0,25 % ≤ C < 0,5 %: T; R49-43-48/20-52/53
0,1 % ≤ C < 0,25 %: T; R49-43-48/20
0,01 % ≤ C < 0,1 %: Xi; R43
028-021-00-0nickel diformate; [1]
formic acid, nickel salt; [2]
formic acid, copper nickel salt [3]		E, H222-101-0 [1]
239-946-6 [2]
268-755-0 [3]		3349-06-2 [1]
15843-02-4 [2]
68134-59-8 [3]		Carc. Cat. 1; R49
Muta. Cat. 3; R68
Repr. Cat. 2; R61
T; R48/23
R42/43
N; R50-53		T; N
R: 49-61-42/43-48/23-68-50/53
S: 53-45-60-61		C ≥ 25 %: T, N; R49-61-42/43-48/23-68-50/53
2,5 % C < 25 %: T, N; R49-61-42/43-48/23-68-51/53
1 % ≤ C < 2,5%: T; R49-61-42/43-48/23-68-52/53
0,5 % ≤ C < 1 %: T; R49-61-43-48/20-52/53
0,25 % ≤ C < 0,5 %: T; R49-43-48/20-52/53
0,1 % ≤ C < 0,25 %: T; R49-43-48/20
0,01 % ≤ C 0,1 %: Xi; R43
028-022-00-6nickel di(acetate); [1]
nickel acetate [2]		E, H206-761-7 [1]
239-086-1 [2]		373-02-4 [1]
14998-37-9 [2]		Carc. Cat. 1; R49
Muta. Cat. 3; R68
Repr. Cat. 2; R61
T; R48/23
Xn; R20/22
R42/43
N; R50-53		T; N
R: 49-61-20/22-42/43-48/23-68-50/53
S: 53-45-60-61		C ≥ 25 %: T, N; R49-61-20/22-42/43-48/23-68-50/53
2,5 % ≤ C < 25 %: T, N: R49-61-42/43-48/23-68-51/53
1 % ≤ C < 2,5 %: T; R49-61-42/43-48/23-68-52/53
0,5 % ≤ C < 1 %: T; R49-61-43-48/20-52/53
0,25 % ≤ C 0,5 %: T; R49-43-48/20-52/53
0,1 % ≤ C < 0,25 %: T; R49-43-48/20
0,01 % ≤ C < 0,1 %: Xi; R43
028-024-00-7nickel dibenzoateE, H209-046-8553-71-9Carc. Cat. 1; R49
Muta. Cat. 3; R68
Repr. Cat. 2; R61
T; R48/23
R42/43
N; R50-53		T; N
R: 49-61-42/43-48/23-68-50/53
S: 53-45-60-61		C ≥ 25 %: T, N; R49-61-42/43-48/23-68-50/53
2,5 % ≤ C < 25 %: T, N; R49-61-42/43-48/23-68-51/53
1 % ≤ C < 2,5 %: T; R49-61-42/43-48/23-68-52/53
0,5 % ≤ C < 1 %: T; R49-61-43-48/20-52/53
0,25 % ≤ C < 0,5 %: T; R49-43-48/20-52/53
0,1 % ≤C < 0,25 %: T; R49-43-48/20
0,01 % ≤ C < 0,1 %: Xi; R43
028-025-00-2nickel bis(4-cyclohexylbutyrate)E, H223-463-23906-55-6Carc. Cat. 1; R49
Muta. Cat. 3; R68
Repr. Cat. 2; R61
T; R48/23
R42/43
N; R50-53		T; N
R: 49-61-42/43-48/23-68-50/53
S: 53-45-60-61		C ≥ 25 %: T, N; R49-61-42/43-48/23-68-50/53
2,5 % ≤ C < 25 %: T, N; R49-61-42/43-48/23-68-51/53
1 % ≤ C < 2,5 %: T; R49-61-42/43-48/23-68-52/53
0,5 % ≤ C < 1 %: T; R49-61-43-48/20-52/53
0,25 % ≤ C < 0,5 %: T; R49-43-48/20-52/53
0,1 % ≤ C < 0,25 %: T; R49-43-48/20
0,01 % ≤ C < 0,1 %: Xi; R43
028-026-00-8nickel(II) stearate;
nickel(II) octadecanoate		E, H218-744-12223-95-2Carc. Cat. 1; R49
Muta. Cat. 3; R68
Repr. Cat. 2; R61
T; R48/23
R42/43
N; R50-53		T; N
R: 49-61-42/43-48/23-68-50/53
S: 53-45-60-61		C ≥ 25 %: T, N; R49-61-42/43-48/23-68-50/53
2,5 % ≤ C < 25 %: T, N; R49-61-42/43-48/23-68-51/53
1 % ≤ C < 2,5 %: T; R49-61-42/43-48/23-68-52/53
0,5 % ≤ C < 1 %: T; R49-61-43-48/20-52/53
0,25 % ≤ C < 0,5 %: T; R49-43-48/20-52/53
0,1 % ≤ C < 0,25 %: T; R49-43-48/20
0,01 % ≤ C < 0,1 %: Xi; R43
028-027-00-3nickel dilactateE, H—16039-61-5Carc. Cat. 1; R49
Muta. Cat. 3; R68
Repr. Cat. 2; R61
T; R48/23
R42/43
N; R50-53		T; N
R: 49-61-42/43-48/23-68-50/53
S: 53-45-60-61		C ≥ 25 %: T, N; R49-61-42/43-48/23-68-50/53
2,5 % ≤ C < 25 %: T, N; R49-61-42/43-48/23-68-51/53
1 % ≤ C < 2,5 %: T; R49-61-42/43-48/23-68-52/53
0,5 % ≤ C < 1 %: T; R49-61-43-48/20-52/53
0,25 % ≤ C < 0,5 %: T; R49-43-48/20-52/53
0,1 % ≤ C < 0,25 %: T; R49-43-48/20
0,01 % ≤ C < 0,1 %: Xi; R43
028-028-00-9nickel(II) octanoateE, H225-656-74995-91-9Carc. Cat. 1; R49
Muta. Cat. 3; R68
Repr. Cat 2; R61
T; R48/23
C; R35
R42/43
N; R50-53		T; C; N
R: 49-61-35-42/43-48/23-68-50/53
S: 53-45-60-61		C ≥ 25 %: T, C, N; R49-61-35-42/43-48/23-68-50/53
10 % ≤ C < 25 %: T, C, N; R49-61-35-42/43-48/23-68-51/53
5 % ≤ C < 10 %: T, N; R49-61-34-42/43-48/23-68-51/53
2,5 % ≤ C < 5 %: T, N; R49-61-36/38-42/43-48/23-68-51/53
1 % ≤ C < 2,5 %: T; R49-61-36/38-42/43-48/23-68-52/53
0,5 % ≤ C < 1 %: T; R49-61-43-48/20-52/53
0,25 % ≤ C < 0,5 %: T; R49-43-48/20-52/53
0,1 % ≤ C < 0,25 %: T; R49-43-48/20
0,01 % ≤ C < 0,1 %: Xi; R43
028-029-00-4nickel difluoride; [1]
nickel dibromide; [2]
nickel diiodide; [3]
nickel potassium fluoride [4]		E, H233-071-3 [1]
236-665-0 [2]
236-666-6 [3]
- [4]		10028-18-9 [1]
13462-88-9 [2]
13462-90-3 [3]
11132-10-8 [4]		Carc. Cat. 1; R49
Muta. Cat. 3; R68
Repr. Cat. 2; R61
T; R48/23
R42/43
N; R50-53		T; N
R: 49-61-42/43-48/23-68-50/53
S: 53-45-60-61		C ≥ 25 %: T, N; R49-61-42/43-48/23-68-50/53
2,5 % ≤ C < 25 %: T, N; R49-61-42/43-48/23-68-51/53
1 % ≤ C < 2,5 %: T; 49-61-42/43-48/23-68-52/53
0,5 % ≤ C < 1 %: T; R49-61-43-48/20-52/53
0,25 % ≤ C < 0,5 %: T; 49-43-48/20-52/53
0,1 % ≤ C < 0,25 %: T; R49-43-48/20
0,01 % ≤ C < 0,1 %: Xi; R43
028-030-00-Xnickel hexafluorosilicateE, H247-430-726043-11-8Carc. Cat. 1; R49
Muta. Cat. 3; R68
Repr. Cat. 2; R61
T; R48/23
R42/43
N; R50-53		T; N
R: 49-61-42/43-48/23-68-50/53
S: 53-45-60-61		C ≥ 25 %: T, N; R49-61-42/43-48/23-68-50/53
2,5 % ≤ C < 25 %: T, N; R49-61-42/43-48/23-68-51/53
1 % ≤ C < 2,5 %: T; R49-61-42/43-48/23-68-52/53
0,5 % ≤ C < 1 %: T; R49-61-43-48/20-52/53
0,25 % ≤ C < 0,5 %: T; R49-43-48/20-52/53
0,1 % ≤ C < 0,25 %: T; R49-43-48/20
0,01 % ≤ C < 0,1 %: Xi; R43
028-031-00-5nickel selenateE, H239-125-215060-62-5Carc. Cat. 1; R49
Muta. Cat. 3; R68
Repr. Cat. 2; R61
T; R48/23
R42/43
N; R50-53		T; N
R: 49-61-42/43-48/23-68-50/53
S: 53-45-60-61		C ≥ 25 %: T, N; R49-61-42/43-48/23-68-50/53
2,5 % ≤ C < 25 %: T, N; R49-61-42/43-48/23-68-51/53
1 % ≤ C < 2,5 %: T; R49-61-42/43-48/23-68-52/53
0,5 % ≤ C < 1 %: T; R49-61-43-48/20-52/53
0,25 % ≤ C < 0,5 %: T; R49-43-48/20-52/53
0,1 % ≤ C < 0,25 %: T; R49-43-48/20
0,01 % ≤ C < 0,1 %: Xi; R43
028-032-00-0nickel hydrogen phosphate; [1]
nickel bis(dihydrogen phosphate); [2]
trinickel bis(orthophosphate); [3]
dinickel diphosphate; [4]
nickel bis(phosphinate); [5]
nickel phosphinate; [6]
phosphoric acid, calcium nickel salt; [7]
diphosphoric acid, nickel(II) salt [8]		E, H238-278-2 [1]
242-522-3 [2]
233-844-5 [3]
238-426-6 [4]
238-511-8 [5]
252-840-4 [6]
- [7]
- [8]		14332-34-4 [1]
18718-11-1 [2]
10381-36-9 [3]
14448-18-1 [4]
14507-36-9 [5]
36026-88-7 [6]
17169-61-8 [7]
19372-20-4 [8]		Carc. Cat. 1; R49
T; R48/23
R42/43
N; R50-53		T; N
R: 49-42/43-48/23-50/53
S: 53-45-60-61
028-033-00-6diammonium nickel hexacyanoferrateE, H—74195-78-1Carc. Cat. 1; R49
T; R48/23
R42/43
N; R50-53		T; N
R: 49-42/43-48/23-50/53
S: 53-45-60-61
028-034-00-1nickel dicyanideE, H209-160-8557-19-7Carc. Cat. 1; R49
T; R48/23
R42/43
R32
N; R50-53		T; N
R: 49-32-42/43-48/23-50/53
S: 53-45-60-61
028-035-00-7nickel chromateE, H238-766-514721-18-7Carc. Cat. 1; R49
T; R48/23
R42/43
N; R50-53		T; N
R: 49-42/43-48/23-50/53
S: 53-45-60-61
028-036-00-2nickel(II) silicate; [1]
dinickel orthosilicate; [2]
nickel silicate (3:4); [3]
silicic acid, nickel salt; [4]
trihydrogen hydroxybis[orthosilicato(4-)]trinickelate(3-) [5]		E, H244-578-4 [1]
237-411-1 [2]
250-788-7 [3]
253-461-7 [4]
235-688-3 [5]		21784-78-1 [1]
13775-54-7 [2]
31748-25-1 [3]
37321-15-6 [4]
12519-85-6 [5]		Carc. Cat. 1; R49
T; R48/23
R43
N; R50-53		T; N
R: 49-43-48/23-50/53
S: 53-45-60-61
028-037-00-8dinickel hexacyanoferrateE, H238-946-314874-78-3Carc. Cat. 1; R49
T; R48/23
R43
N; R50-53		T; N
R: 49-43-48/23-50/53
S: 53-45-60-61
028-038-00-3trinickel bis(arsenate);
nickel(II) arsenate		E, H236-771-713477-70-8Carc. Cat. 1; R45
T; R48/23
R43
N; R50-53		T; N
R: 45-43-48/23-50/53
S: 53-45-60-61
028-039-00-9nickel oxalate; [1]
oxalic acid, nickel salt [2]		E, H208-933-7 [1]
243-867-2 [2]		547-67-1 [1]
20543-06-0 [2]		Carc. Cat. 1; R49
T; R48/23
R43
N: R50-53		T; N
R: 49-43-48/23-50/53
S: 53-45-60-61
028-040-00-4nickel tellurideE, H235-260-612142-88-0Carc. Cat. 1; R49
T; R48/23
R43
N; R50-53		T; N
R: 49-43-48/23-50/53
S: 53-45-60-61
028-041-00-Xtrinickel tetrasulfideE, H—12137-12-1Carc. Cat. 1; R49
T; R48/23
R43
N; R50-53		T; N
R: 49-43-48/23-50/53
S: 53-45-60-61
028-042-00-5trinickel bis(arsenite)E, H—74646-29-0Carc. Cat. 1; R49
T; R48/23
R43
N; R50-53		T; N
R: 49-43-48/23-50/53
S: 53-45-60-61
028-043-00-0cobalt nickel gray periclase;
C.I. Pigment Black 25;
C.I. 77332; [1]
cobalt nickel dioxide; [2]
cobalt nickel oxide [3]		E, H269-051-6 [1]
261-346-8 [2]
- [3]		68186-89-0 [1]
58591-45-0 [2]
12737-30-3 [3]		Carc. Cat. 1; R49
T; R48/23
R43		T
R: 49-43-48/23
S: 53-45
028-044-00-6nickel tin trioxide;
nickel stannate		E, H234-824-912035-38-0Carc. Cat. 1; R49
T; R48/23
R43		T
R: 49-43-48/23
S: 53-45
028-045-00-1nickel triuranium decaoxideE, H239-876-615780-33-3Carc. Cat. 1; R49
T; R48/23
R43		T
R: 49-43-48/23
S: 53-45
028-046-00-7nickel dithiocyanateE, H237-205-113689-92-4Carc. Cat. 1; R49
Muta. Cat. 3;R68
Repr. Cat. 2; R61
T; R48/23
R42/43
R32
N; R50-53		T; N
R: 49-61-32-42/43-48/23-68-50/53
S: 53-45-60-61		C ≥ 25 %: T, N; R49-61-42/43-48/23-68-50/53
2,5 % ≤ C < 25 %: T, N; R49-61-42/43-48/23-68-51/53
1 % ≤ C < 2,5 %: T; R49-61-42/43-48/23-68-52/53
0,5 % ≤ C < 1 %: T; R49-61-43-48/20-52/53
0,25 % ≤ C < 0,5 %: T: R49-61-43-48/20-52/53
0,1 % ≤ C < 0,25 %: T; R49-43-48/20
0,01 % ≤ C < 0,1 %: Xi; R43
028-047-00-2nickel dichromateE, H239-646-515586-38-6Carc. Cat. 1; R49
Muta. Cat. 3; R68
Repr. Cat. 2; R61
T; R48/23
R42/43
N; R50-53		T; N
R: 49-61-42/43-48/23-68-50/53
S: 53-45-60-61		C ≥ 25 %: T, N; R49-61-42/43-48/23-68-50/53
2,5 % ≤ C < 25 %: T, N; R49-61-42/43-48/23-68-51/53
1 % ≤ C < 2,5 %: T; R49-61-42/43-48/23-68-52/53
0,5 % ≤ C < 1 %: T; 49-61-43-48/20-52/53
0,25 % ≤ C < 0,5 %: T; R49-43-48/20-52/53
0,1% ≤ C < 0,25 %: T; R49-43-48/20
0,01 % ≤ C 0,1 %: Xi; R43
028-048-00-8nickel(II) seleniteE, H233-263-710101-96-9Carc. Cat. 1; R49
T; R48/23
R42/43
N; R50-53		T; N
R: 49-42/43-48/23-50/53
S: 53-45-60-61
028-049-00-3nickel selenideE, H215-216-21314-05-2Carc. Cat. 1; R49
T; R48/23
R43
N; R50-53		T; N
R: 49-43-48/23-50/53
S: 53-45-60-61
028-050-00-9silicic acid, lead nickel saltE, H—68130-19-8Carc. Cat. 1: R49
Repr. Cat. 1: R61
Repr. Cat. 3; R62
T; R48/23
R43
N; R50-53		T; N
R: 49-61-43-48/23-62-50/53
S: 53-45-60-61
028-051-00-4nickel diarsenide; [1]
nickel arsenide [2]		E, H235-103-1 [1]
248-169-1 [2]		12068-61-0 [1]
27016-75-7 [2]		Carc. Cat. 1; R49
T; R48/23
R43
N; R50-53		T; N
R: 49-43-48/23-50/53
S: 53-45-60-61
028-052-00-Xnickel barium titanium primrose priderite;
C.I. Pigment Yellow 157;
C.I. 77900		E, H271-853-668610-24-2Carc. Cat. 1: R49
T; R48/23
R43		T
R: 49-43-48/23
S: 53-45
028-053-00-5nickel dichlorate; [1]
nickel dibromate; [2]
ethyl hydrogen sulfate, nickel(II) salt [3]		E, H267-897-0 [1]
238-596-1 [2]
275-897-7 [3]		67952-43-6 [1]
14550-87-9 [2]
71720-48-4 [3]		Carc. Cat. 1; R49
Muta. Cat. 3; R68
Repr. Cat. 2; R61
T; R48/23
R42/43
N; R50-53		T; N
R: 49-61-42/43-48/23-68-50/53
S: 53-45-60-61		C ≥ 25 %: T, N; R49-61-42/43-48/23-68-50/53
2,5 % ≤ C < 25 %: T, N: R49-61-42/43-48/23-68-51/53
1 % ≤ C < 2,5 %: T: R49-61-42/43-48/23-68-52/53
0,5 % ≤ C < 1 %: T; R49-61-43-48/20-52/53
0,25 % ≤ C < 0,5 %: T; R49-43-48/20-52/53
0,1 % ≤ C < 0,25 %: T: R49-43-48/20
0,01 % ≤ C < 0,1 %: Xi; R43
028-054-00-0nickel(II) trifluoroacetate; [1]
nickel(II) propionate; [2]
nickel bis(benzenesulfonate); [3]
nickel(II) hydrogen citrate; [4]
citric acid, ammonium nickel salt; [5]
citric acid, nickel salt; [6]
nickel bis(2-ethylhexanoate); [7]
2-ethylhexanoic acid, nickel salt; [8]
dimethylhexanoic acid nickel salt; [9]
nickel(II) isooctanoate; [10]
nickel isooctanoate; [11]
nickel bis(isononanoate); [12]
nickel(II) neononanoate; [13]
nickel(II) isodecanoate; [14]
nickel(II) neodecanoate; [15]
neodecanoic acid, nickel salt; [16]
nickel(II) neoundecanoate; [17]
bis(D-gluconato- O 1 , O 2 )nickel; [18]
nickel 3,5-bis( tert -butyl)-4-hydroxybenzoate (1:2); [19]
nickel(II) palmitate; [20]
(2-ethylhexanoato- O )(isononanoato- O )nickel; [21]
(isononanoato- O )(isooctanoato- O )nickel; [22]
(isooctanoato- O )(neodecanoato- O )nickel; [23]
(2-ethylhexanoato- O )(isodecanoato- O )nickel; [24]
(2-ethylhexanoato- O )(neodecanoato- O )nickel; [25]
(isodecanoato- O )(isooctanoato- O )nickel; [26]
(isodecanoato- O )(isononanoato- O )nickel; [27]
(isononanoato- O )(neodecanoato- O )nickel; [28]
fatty acids, C 6-19 -branched, nickel salts; [29]
fatty acids, C 8-18 and C 18 -unsaturated, nickel salts; [30]
2,7-naphthalenedisulfonic acid, nickel(II) salt; [31]		E, H240-235-8 [1]
222-102-6 [2]
254-642-3 [3]
242-533-3 [4]
242-161-1 [5]
245-119-0 [6]
224-699-9 [7]
231-480-1 [8]
301-323-2 [9]
249-555-2 [10]
248-585-3 [11]
284-349-6 [12]
300-094-6 [13]
287-468-1 [14]
287-469-7 [15]
257-447-1 [16]
300-093-0 [17]
276-205-6 [18]
258-051-1 [19]
237-138-8 [20]
287-470-2 [21]
287-471-8 [22]
284-347-5 [23]
284-351-7 [24]
285-698-7 [25]
285-909-2 [26]
284-348-0 [27]
287-592-6 [28]
294-302-1 [29]
283-972-0 [30]
- [31]		16083-14-0 [1]
3349-08-4 [2]
39819-65-3 [3]
18721-51-2 [4]
18283-82-4 [5]
22605-92-1 [6]
4454-16-4 [7]
7580-31-6 [8]
93983-68-7 [9]
29317-63-3 [10]
27637-46-3 [11]
84852-37-9 [12]
93920-10-6 [13]
85508-43-6 [14]
85508-44-7 [15]
51818-56-5 [16]
93920-09-3 [17]
71957-07-8 [18]
52625-25-9 [19]
13654-40-5 [20]
85508-45-8 [21]
85508-46-9 [22]
84852-35-7 [23]
84852-39-1 [24]
85135-77-9 [25]
85166-19-4 [26]
84852-36-8 [27]
85551-28-6 [28]
91697-41-5 [29]
84776-45-4 [30]
72319-19-8 [31]		Carc. Cat. 1; R49
Muta. Cat. 3; R68
Repr. Cat. 2; R61
T; R48/23
R42/43
N; R50-53		T; N
R: 49-61-42/43-48/23-68-50/53
S: 53-45-60-61		C ≥ 25 %: T, N; R49-61-42/43-48/23-68-50/53
2,5 % ≤ C < 25 %: T, N; R49-61-42/43-48/23-68-51/53
1 % ≤ C < 2,5 %: T; R49-61-42/43-48/23-68-52/53
0,5 % ≤ C < 1 %: T; R49-61-43-48/20-52/53
0,25 % ≤ C < 0,5 %: T; R49-43-48/20-52/53
0,1 % ≤ C < 0,25 %: T; R49-43-48/20
0,01 % ≤ C < 0,1 %: Xi; R43
028-055-00-6nickel(II) sulfite; [1]
nickel tellurium trioxide; [2]
nickel tellurium tetraoxide; [3]
molybdenum nickel hydroxide oxide phosphate [4]		E, H231-827-7 [1]
239-967-0 [2]
239-974-9 [3]
268-585-7 [4]		7757-95-1 [1]
15851-52-2 [2]
15852-21-8 [3]
68130-36-9 [4]		Carc. Cat. 1; R49
T; R48/23
R42/43
N; R50-53		T; N
R: 49-42/43-48/23-50/53
S: 53-45-60-61
028-056-00-1nickel boride (NiB); [1]
dinickel boride; [2]
trinickel boride; [3]
nickel boride; [4]
dinickel silicide; [5]
nickel disilicide; [6]
dinickel phosphide; [7]
nickel boron phosphide [8]		E, H234-493-0 [1]
234-494-6 [2]
234-495-1 [3]
235-723-2 [4]
235-033-1 [5]
235-379-3 [6]
234-828-0 [7]
- [8]		12007-00-0 [1]
12007-01-1 [2]
12007-02-2 [3]
12619-90-8 [4]
12059-14-2 [5]
12201-89-7 [6]
12035-64-2 [7]
65229-23-4 [8]		Carc. Cat. 1; R49
T; R48/23
R43
N; R50-53		T; N
R: 49-43-48/23-50/53
S: 53-45-60-61
028-057-00-7dialuminium nickel tetraoxide; [1]
nickel titanium trioxide; [2]
nickel titanium oxide; [3]
nickel divanadium hexaoxide; [4]
cobalt dimolybdenum nickel octaoxide; [5]
nickel zirkonium trioxide; [6]
molybdenum nickel tetraoxide; [7]
nickel tungsten tetraoxide; [8]
olivine, nickel green; [9]
lithium nickel dioxide; [10]
molybdenum nickel oxide; [11]		E, H234-454-8 [1]
234-825-4 [2]
235-752-0 [3]
257-970-5 [4]
268-169-5 [5]
274-755-1 [6]
238-034-5 [7]
238-032-4 [8]
271-112-7 [9]
- [10]
- [11]		12004-35-2 [1]
12035-39-1 [2]
12653-76-8 [3]
52502-12-2 [4]
68016-03-5 [5]
70692-93-2 [6]
14177-55-0 [7]
14177-51-6 [8]
68515-84-4 [9]
12031-65-1 [10]
12673-58-4 [11]		Carc. Cat. 1; R49
T; R48/23
R43		T
R: 49-43-48/23
S: 53-45
028-058-00-2cobalt lithium nickel oxideE442-750-5—Carc. Cat. 1; R49
T+; R26
T; R48/23
R43
N; R50-53		T+; N
R: 49-26-43-48/23-50/53
S: 53-45-60-61
029-014-00-5mixture of: 2,2′-[ cis -1,2-cyclohexanediylbis(nitrilomethylidene)]bis[phenolate] N,N′,O,O′ -copper complex;
2,2′-[ trans -1,2-cyclohexanediylbis(nitrilomethylidyne)]bis[phenolate] N,N′,O,O′ -copper complex		419-610-7171866-24-3Xn; R48/22
N; R51-53		Xn; N
R: 48/22-51/53
S: (2-)22-36-61
030-012-00-1aluminium-magnesium-zinc-carbonate-hydroxide423-570-6169314-88-9R52-53R: 52/53
S: 61
030-015-00-8tetrazinc(2+)bis(hexacyanocobalt(3+))diacetate440-060-9—N; R51-53N
R: 51/53
S: 61
042-005-00-0mixture of: mono- and di-glycerols of canola oil;
canola oil acid amide of branched 1,3-propanediamine, N -[3-(tridecyloxy)-propyl];
N,N -diorgano dithiocarbamate molybdenum complex		434-240-6—R43
N; R51-53		Xi; N
R: 43-51/53
S: (2-)24-37-61
050-023-00-5mixture of: bis[(2-ethyl-1-oxohexyl)oxy]dioctyl stannane;
bis[((2-ethyl-1-oxohexyl)oxy)dioctylstannyl]oxide;
bis(1-phenyl-1,3-decanedionyl)dioctyl stannane;
((2-ethyl-1-oxohexyl)oxy)-(1-phenyl-1,3-decanedionyl)dioctyl stannane		422-920-5—Xn; R48/22
N; R50-53		Xn; N
R: 48/22-50/53
S: (2-)23-36-60-61		C ≥ 10 %: Xn, N; R48/22-50/53
2,5 % ≤ C < 10 %: N; R50/53
0,25 % ≤ C < 2,5 %: N; R51/53
0,025 % ≤ C < 0,25 %: R52/53
050-024-00-0mixture of: tri- p -tolyltin hydroxide;
hexa- p -tolyl-distannoxane		432-230-6—T; R48/25
Xn; R22
Xi; R38-41
R43
N; R50-53		T; N
R: 22-38-41-43-48/25-50/53
S: (1/2-)22-26-36/37/39-45-60-61
064-001-00-8gadolinium(III)sulfite trihydrate456-900-251285-81-5N; R51-53N
R: 51/53
S: 61
078-011-00-5hydroxydisulfito platinum(II) acid423-310-161420-92-6Xn; R22-48/20/21/22
C; R35
R42/43
R52-53		C
R: 22-35-42/43-48/20/21/22-52/53
S: (1/2-)23-24-26-28-36/37/39-45-61
078-012-00-0platinum(IV) nitrate/nitric acid solution432-400-1—C; R35
N; R50-53		C; N
R: 35-50/53
S: (1/2-)26-36/37/39-45-60-61
082-012-00-6barium calcium cesium lead samarium strontium bromide chloride fluoride iodide europium doped431-780-4199876-46-5Xn; R22-48/22
N; R51-53		Xn; N
R: 22-48/22-51/53
S: (2-)22-36-61
601-080-00-5mixture of: sec -butylphenyl(phenyl)methane, mixed isomers;
1-( sec -butylphenyl(phenyl)-2-phenylethane, mixed isomers;
1-( sec -butylphenyl-1-phenylethane, mixed isomers		431-100-6—N; R50-53N
R: 50/53
S: 60-61
601-081-00-0cyclohexadeca-1,9-diene431-730-14277-06-9Xi; R38
R43
R53		Xi
R: 38-43-53
S: (2-)36/37-61
601-082-00-6mixture of: endo-2-methyl-exo-3-methyl-exo-2-[(exo-3-methylbicyclo[2.2.1]hept-exo-2-yl)methyl]bicyclo[2.2.1]heptane;
exo-2-methyl-exo-3-methyl-endo-2-[(endo-3-methylbicyclo[2.2.1]hept-exo-2-yl)methyl]bicyclo[2.2.1]heptane		434-420-4—Xi; R38-41
N; R50-53		Xi; N
R: 38-41-50/53
S: (2-)23-26-37/39-57-60-61
601-083-00-15-endo-hexyl-bicyclo[2.2.1]hept-2-ene435-000-322094-83-3Xn; R65
Xi; R38
R53		Xn
R: 38-65-53
S: (2-)37-62-61
601-084-00-7mixture of: 5-endo-butyl-bicyclo[2.2.1]hept-2-ene;
5-exo-butyl-bicyclo[2.2.1]hept-2-ene (80:20)		435-180-3—Xn; R65
Xi; R38
N; R50-53		Xn; N
R: 38-65-50/53
S: (2-)37-62-60-61
602-105-00-2sodium 1,1,2,2,3,3,4,4,4-nonafluoro-1-butanesulfinate422-100-7102061-82-5Xi; R41
R43		Xi
R: 41-43
S: (2-)24-26-37/39
602-106-00-82-bromo-4,6-difluoroaniline429-430-0444-14-4Xn; R22
N; R51-53		Xn; N
R: 22-51/53
S: (2-)25-61
602-107-00-33,3,4,4-tetrafluoro-4-iodo-1-butene439-500-233831-83-3Xn; R22
Xi; R38
N; R51-53		Xn; N
R: 22-38-51/53
S: (2-)37-61
602-108-00-9(2,3,5,6-tetrafluorophenyl)methanol443-840-74084-38-2Xn; R22
Xi; R36
R43		Xn
R: 22-36-43
S: (2-)26-36/37
603-211-00-12,3-epoxypropyltrimethylammonium chloride … %;
glycidyl trimethylammonium chloride … %		B E221-221-03033-77-0Carc. Cat. 2; R45
Muta. Cat. 3; R68
Repr. Cat. 3; R62
Xn; R21/22-48/22
Xi; R41
R43
R52-53		T
R: 45-21/22-41-43-48/22-62-68-52/53
S: 53-45-61
603-212-00-71,3,4,6,7,8-hexahydro-4,6,6,7,8,8-hexamethylindeno[5,6- c ]pyran;
galaxolide;
(HHCB)		214-946-91222-05-5N; R50-53N
R: 50/53
S: 60-61
603-213-00-22-methoxy-2-methylbutane;
tert -amyl methyl ether		213-611-4994-05-8F; R11
Xn; R22
R67		F; Xn
R: 11-22-67
S: (2-)9-16-23-33
603-214-00-81,1-diisopropoxycyclohexane413-740-81132-95-2C; R34C
R: 34
S: (1/2-)23-26-36/37/39-45
603-215-00-31-hydroxy-4-fluoro-1,4-diazoniabicyclo[2.2.2]octane bis(tetrafluoroborate)418-330-2162241-33-0E; R2
Xn; R22-48/22
Xi; R41
R43
N; R50-53		E; Xn; N
R: 2-22-41-43-48/22-50/53
S: (2-)22-26-36/37/39-60-61
603-216-00-9cis -1-amino-2,3-dihydro-1 H -inden-2-ol422-660-27480-35-5Xi; R41
R43
R52-53		Xi
R: 41-43-52/53
S: (2-)24-26-37/39-61
603-217-00-42,4,6-tri- tert -butylphenyl 2-butyl-2-ethyl-1,3-propanediolphosphite423-560-1161717-32-4R43
R53		Xi
R: 43-53
S: (2-)24-37/39-61
603-220-00-01-{benzyl[2-(2-methoxyphenoxy)ethyl]amino}-3-(9 H -carbazol-4-yloxy)propan-2-ol432-890-572955-94-3R53R: 53
S: 61
603-221-00-61-(2-amino-5-chlorophenyl)-2,2,2-trifluoro-1,1-ethanediol, hydrochloride;
[containing < 0,1 % 4-chloroaniline (EC No 203-401-0)]		433-580-2214353-17-0Xn; R22
C; R34
N; R51-53		C; N
R: 22-34-51/53
S: (1/2-)26-36/37/39-45-61
603-221-01-31-(2-amino-5-chlorophenyl)-2,2,2-trifluoro-1,1-ethanediol, hydrochloride;
[containing ≥ 0,1 % 4-chloroaniline (EC No 203-401-0)]		E433-580-2214353-17-0Carc. Cat. 2; R45
Xn; R22
C; R34
N; R51-53		T; N
R: 45-22-34-51/53
S: 53-45-61
603-222-00-1(2 R ,3 S ,4 R ,5 R ,7 R ,9 R ,10 R ,11 S ,12 S ,13 R )-10-[(4-dimethylamino-3-hydroxy-6-methyltetrahydropyran-2-yl)oxy]-2-ethyl-3,4,12-trihydroxy-9-methoxy-3,5,7,9,11,13-hexamethyl-6,14-dioxo-1-oxacyclotetradecane433-820-6118058-74-5Xi; R36Xi
R: 36
S: (2-)26
603-223-00-72-cyclopentylidene cyclopentanol;
1,1′-bi(cyclopentyliden)-2-ol		434-270-16261-30-9Xi; R38-41
R52-53		Xi
R: 38-41-52/53
S: (2-)26-37/39-61
603-224-00-23-ethoxy-1,1,1,2,3,4,4,5,5,6,6,6-dodecafluoro-2-(trifluoromethyl)-hexane435-790-1297730-93-9R53R: 53
S: 61
603-225-00-8erythromycin A9-oxime (E);
(3 R ,4 S ,5 S ,6 R ,7 R ,9 R ,11 R ,12 R ,13 S ,14 R )-4-((2,6-didesoxy-3- C -methyl-3- O -methyl-α- L -ribo-hexopiranosyl)oxy)-14-ethyl-7,12,13-trihydroxy-3,5,7,9,11,13-hexamethyl-6-((3,4,6-tridesoxy-3-dimethylamino-β-D-xylohexapiranosyl)oxy)oxacyclotetradecan-2-ona-10-oxime (E)		437-070-013127-18-9N; R51-53N
R: 51/53
S: 61
603-226-00-34,4′(4-(4-methoxyphenyl)-1,3,5-triazin-2,4-diyl)bisbenzene-1,3-diol444-500-01440-00-2R52-53R: 52/53
S: 61
603-227-00-9α-hydro-ω-[[[(1,1-dimethylethyl)dioxy]carbonyl]oxy]-poly[oxy(methyl-1,2-ethanediyl)] ether with 2,2-bis(hydroxymethyl)-1,3-propanediol (4:1);
reaction product of: α-hydro-ω-((chlorocarbonyl)oxy)-poly(oxy(methyl-1,2-ethanediyl)) ether with 2,2-bis(hydroxymethyl)-1,3-propanediol with potassium 1,1-dimethylethylperoxalate		445-060-2203574-04-3O; R7
N; R50-53		O; N
R: 7-50/53
S: (2-)3/7-14-36/37/39-60-61
603-228-00-4(+/-)-( R,R** )-6-fluoro-3,4-dihydro-2-oxiranyl-2 H -1-benzopyran;
6-fluoro-2-(2-oxiranyl)chromane		419-620-1—R43
N; R51-53		Xi; N
R: 43-51/53
S: (2-)36/37-61
603-229-00-Xsodium ( Z )-3-chloro-3-(4-chlorophenyl)-1-hydroxy-2-propene-1-sulfonate420-800-7—Xi; R38-41
R43
N; R50-53		Xi; N
R: 38-41-43-50/53
S: (2-)24-26-37/39-60-61
603-230-00-52,6,6,7,8,8-hexamethyldecahydro-2 H -indeno[4,5-b]furan440-030-5—Xi; R38-41
R53		Xi
R: 38-41-53
S: (2-)26-37/39-61
603-231-00-0( S )-1,1-diphenyl-1,2-propanediol443-220-6—R52-53R: 52/53
S: 22-61
603-232-00-63,3,8,8,10,10-hexamethyl-9-[1-(4-oxiranylmethoxy-phenyl)-ethoxy]-1,5-dioxa-9-aza-spiro[5.5]undecane444-420-6—R53R: 53
S: 61
603-233-00-1mixture of: 4-(1,3a,4,6,7,7a-hexahydro-4,7-methanoinden-5-ylidene)-3-methylbutan-2-ol;
4-(3,3a,4,6,7,7a-hexahydro-4,7-methanoinden-5-ylidene)-3-methylbutan-2-ol;
1-(1,3a,4,6,7,7a-hexahydro-4,7-methanoinden-5-ylidene)pentan-3-ol;
1-(3,3a,4,6,7,7a-hexahydro-4,7-methanoinden-5-ylidene)pentan-3-ol;
( E )-4-(3a,4,5,6,7,7a-hexahydro-1 H -4,7-methanoinden-5-yl)-3-methylbut-3-en-2-ol;
( E )-4-(3a,4,5,6,7,7a-hexahydro-3 H -4,7-methanoinden-5-yl)-3-methylbut-3-en-2-ol		444-430-0—N; R51-53N
R: 51/53
S: 61
603-234-00-7(1 R ,4 R )-4-methoxy-2,2,7,7-tetramethyltricyclo(6.2.1.0(1,6))undec-5-ene444-480-3—Xi; R38
N; R51-53		Xi; N
R: 38-51/53
S: (2-)37-61
604-074-00-0tetrabromobisphenol-A;
2,2′,6,6′-tetrabromo-4,4′-isopropylidenediphenol		201-236-979-94-7N; R50-53N
R: 50/53
S: 60-61
604-075-00-64-(1,1,3,3-tetramethylbutyl)phenol;
4- tert -octylphenol		205-426-2140-66-9Xi; R38-41
N; R50-53		Xi; N
R: 38-41-50/53
S: (2-)26-37/39-60-61		C ≥ 20 %: Xi, N; R38-41-50/53
10 % ≤ C < 20 %: Xi, N; R41-50/53
5 % ≤ C < 10 %: Xi, N; R36-50/53
2,5 % ≤ C < 5 %: N; R50/53
0,25 % ≤ C < 2,5 %: N; R51/53
0,025 % ≤ C < 0,25 %: R52/53
604-076-00-1phenolphthalein201-004-777-09-8Carc. Cat. 2; R45
Muta. Cat. 3; R68
Repr. Cat. 3; R62		T
R: 45-62-68
S: 53-45		C ≥ 5 %: T; R45-62-68
1 % ≤ C < 5 %: T; R45-68
604-077-00-72-benzotriazol-2-yl-4-methyl-6-(2-methylallyl)phenol419-750-998809-58-6R53R: 53
S: 61
604-079-00-84,4′-(1,3-phenylene-bis(1-methylethylidene))bis-phenol428-970-413595-25-0Repr.Cat.3; R62
R43
N; R51-53		Xn; N
R: 43-62-51/53
S: (2-)22-36/37-61
604-080-00-34-fluoro-3-trifluoromethylphenol432-560-061721-07-1Xn; R20
C; R35
R43
N; R51-53		C; N
R: 20-35-43-51/53
S: (1/2-)26-28-36/37/39-45-61
604-081-00-91,1-bis(4-hydroxyphenyl)-1-phenylethane433-130-51571-75-1N; R50-53N
R: 50/53
S: 25-60-61
604-082-00-42-chloro-6-fluoro-phenolE433-890-82040-90-6Muta.Cat.2; R46
Repr.Cat.3; R62
Xn; R22
C; R34
R43
N; R51-53		T; N
R: 46-22-34-43-62-51/53
S: 53-45-61
604-083-00-X4,4′-sulfonylbisphenol, polymer with ammonium chloride(NH 4 Cl), pentachlorophosphorane and phenol439-270-3260408-02-4R53R: 53
S: 61
604-084-00-51-ethoxy-2,3-difluorobenzene441-000-4121219-07-6Xn; R22
R52-53		Xn
R: 22-52/53
S: (2-)23-61
604-087-00-1mixture of: 1,2-naphthoquinonediazide-5-sulfonylchloride (or sulfonic acid)monoester with 4,4′-(1-(4-(1-(4-hydroxyphenyl)-1-methylethyl)phenyl)ethylidene)bisphenol;
1,2-naphthoquinonediazide-5-sulfonylchloride (or sulfonic acid)diester with 4,4′-(1-(4-(1-(4-hydroxyphenyl)-1-methylethyl)phenyl)ethylidene)bisphenol;
1,2-naphthoquinonediazide-5-sulfonylchloride (or sulfonic acid)triester with 4,4′-(1-(4-(1-(4-hydroxyphenyl)-1-methylethyl)phenyl)ethylidene)bisphenol		433-640-8—F; R17
R44
R53		F
R: 17-44-53
S: (2-)15-22-61
604-089-00-22-methyl-5- tert -butylthiophenol444-970-7—R10
Repr.Cat.3; R63
Xn; R48/20/22-65
Xi; R36/38
R43
R67
N; R50-53		Xn; N
R: 10-36/38-43-48/20/22-63-65-67-50/53
S: (2-)26-36/37-62-60-61
605-037-00-1trans -3-[2-(7-chloro-2-quinolinyl)vinyl]benzaldehyde;
3-[( E )-2-(7-chloro-2-quinolinyl)vinyl]benzaldehyde		421-800-1120578-03-2R53R: 53
S: 22-61
605-038-00-73-methyl-5-phenylpentan-1-al433-900-055066-49-4Xn; R22
Xi; R38
R43
N; R51-53		Xn; N
R: 22-38-43-51/53
S: (2-)36/37-61
605-039-00-23,4-dihydroxy-5-nitrobenzaldehyde441-810-8116313-85-0Xn; R22
Xi; R41
R43		Xn
R: 22-41-43
S: (2-)22-24-26-37/39
606-124-00-71-cyclopropyl-3-(2-methylthio-4-trifluoromethylphenyl)-1,3-propanedione421-080-7161462-35-7Xn; R48/22
N; R50-53		Xn; N
R: 48/22-50/53
S: (2-)36-60-61
606-125-00-21-benzylimidazolidine-2,4-dione421-340-16777-05-5Xn; R22Xn
R: 22
S: (2-)22
606-126-00-81,4-bis(2,3-dihydroxypropylamino)anthraquinone421-470-799788-75-7N; R51-53N
R: 51/53
S: 61
606-128-00-92,2′-(1,3-phenylene)bis[5-chloro-1 H -isoindole]-1,3(2 H )-dione422-650-8148935-94-8R53R: 53
S: 61
606-129-00-45-amino-[2 S -di(methylphenyl)amino]-1,6-diphenyl-4 Z -hexen-3-one;
(2 S ,4 Z )-5-amino-2-(dibenzylamino)-1,6-diphenylhex-4-en-3-one		423-090-7156732-13-7R53R: 53
S: 61
606-130-00-X4-(1,4-dioxa-spiro[4.5]dec-8-yl)-cyclohexanone423-860-256309-94-5R43
R52-53		Xi
R: 43-52/53
S: (2-)24-37-61
606-131-00-5cyclic 3-(1,2-ethanediylacetale)-estra-5(10),9(11)-diene-3,17-dioneE427-230-85571-36-8Repr. Cat. 2; R60
Xn; R48/22
N; R51-53		T; N
R: 60-48/22-51/53
S: 53-45-61
606-132-00-0(6β)-6,19-epoxyandrost-4-ene-3,17-dione433-490-36563-83-3R43
R52-53		Xi
R: 43-52/53
S: (2-)24-37-61
606-134-00-1androsta-1,4,9(11)-triene-3,17-dione433-560-315375-21-0Repr. Cat.3; R62Xn
R: 62
S: (2-)22-36/37
606-135-00-7cyclohexadecanone438-930-82550-52-9R53R: 53
S: 61
606-136-00-2(3 S ,6 R ,9 S ,12 R ,15 S ,18 R ,21 S ,24 R )-6,18-dibenzyl-3,9,15,21-tetraisobutyl-4,10,12,16,22,24-hexamethyl-1,7,13,19-tetraoxa-4,10,16,22-tetraazacyclo-tetracosane-2,5,8,11,14,17,20,23-octaone444-350-6133413-70-4Xi; R36
R53		Xi
R: 36-53
S: (2-)26-61
606-137-00-8trans -7,7′-dimethyl-(4 H ,4 H′ )-(2,2′)bi[benzo[1,4]thiazinylidene]-3,3′-dione444-750-0211387-26-7R53R: 53
S: 22-61
606-138-00-3(2-butyl-5-nitrobenzofuran-3-yl)[4-(3-dibutylaminopropoxy)phenyl]methanone444-800-1141645-23-0R10
Xn; R22-48/22
Xi; R38-41
R43
N; R50-53		Xn; N
R: 10-22-38-41-43-48/22-50/53
S: (2-)23-26-36/37/39-60-61		C ≥ 25 %: Xn, N; R22-38-41-43-48/22-50/53
20 % ≤ C < 25 %: Xn, N; R38-41-43-48/22-50/53
10 % ≤ C < 20 %: Xn, N; R41-43-48/22-50/53
5 % ≤ C < 10 %: Xi, N; R36-43-50/53
2,5 % ≤ C < 5 %: Xi, N; R43-50/53
1 % ≤ C < 2,5 %: Xi, N; R43-51/53
0,25 % ≤ C < 1 %: N; R51/53
0,025 % ≤ C < 0,25 %: R52/53
606-139-00-9( S )-4-(3,4-dichlorophenyl)-3,4-dihydro-2 H -naphthalen-1-one444-830-5124379-29-9R53R: 53
S: 61
606-140-00-42-hydroxy-1-(4-(4-(2-hydroxy-2-methylpropionyl)benzyl)phenyl)-2-methylpropan-1-one444-860-9474510-57-1Xn; R48/22
N; R50-53		Xn; N
R: 48/22-50/53
S: (2-)22-36-60-61
606-141-00-Xsodium 3-(methoxycarbonyl)-4-oxo-3,4,5,6-tetrahydro-2-pyridinolate418-410-7—Xi; R36Xi
R: 36
S: (2-)26
606-142-00-5mixture of: (1 RS ,2 SR ,7 SR ,8 SR,E ) 9 and 10-ethylidene-3-oxatricyclo[6.2.1.0( 2,7 )]undecan-4-one;
(1 RS ,2 SR ,7 SR ,8 SR,Z )-10-ethylidene-3-oxatricyclo[6.2.1.0( 2,7 )]undecan-4-one;
(1 RS ,2 SR ,7 SR ,8 SR,Z )-9-ethylidene-3-oxatricyclo[6.2.1.0( 2,7 )]undecan-4-one		434-290-9—Xn; R22
N; R51-53		Xn; N
R: 22-51/53
S: (2-)61
607-580-00-Xethyl 7-chloro-1-(2,4-difluorophenyl)-6-fluoro-1,4-dihydro-4-oxo-1,8-naphthyridine-3-carboxylate422-360-1100491-29-0R43
N; R51-53		Xi; N
R: 43-51/53
S: (2-)22-24-37-61
607-618-00-5menadione sodium bisulfite;
2-naphthalenesulfonic acid,1,2,3,4-tetrahydro-2-methyl-1,4-dioxo-, sodium salt		204-987-0130-37-0Xi; R36/38
N; R50-53		Xi; N
R: 36/38-50/53
S: (2-)24/25-60-61
607-619-00-0menadione nicotinamide bisulfite;
1,2,3,4-tetrahydro-2-methyl-1,4-dioxonaphthalene-2-sulfonic acid, compound with nicotin-3-amide (1:1)		277-543-773581-79-0Xi; R36/38
N; R50-53		Xi; N
R: 36/38-50/53
S: (2-)24/25-60-61
607-620-00-6trisodium nitrilotriacetate225-768-65064-31-3Carc. Cat. 3; R40
Xn; R22
Xi; R36		Xn
R: 22-36-40
S: (2-)26-36/37-46		C ≥ 25 %: Xn; R22-36-40
20 ≤ % C < 25 %: Xn; R36-40
5 ≤ % C < 20 %: Xn; R40
607-621-00-1milbemectin (ISO);
[mixture of milbemycin A3 (CAS No 51596-10-2) and milbemycin A4 (CAS No 51596-11-3) (30:70)]		——Xn; R20/22
N; R50-53		Xn; N
R: 20/22-50/53
S: (2-)46-60-61		C ≥ 25 %: Xn, N; R20/22-50/53
0,25 % ≤ C < 25 %: N; R50/53
0,025 % ≤ C < 0,25 %: N; R51/53
0,0025 % ≤ C < 0,025 %: R52/53
607-622-00-72-ethylhexyl-2-ethylhexanoate231-057-17425-14-1Repr. Cat. 3; R63Xn
R: 63
S: (2-)36/37
607-623-00-2diisobutyl phthalate201-553-284-69-5Repr. Cat. 2; R61
Repr. Cat. 3; R62		T
R: 61-62
S: 53-45		C ≥ 25 %: T; R61-62
5 % ≤ C < 25 %: Xn; R62
607-624-00-8perfluorooctane sulfonic acid;
heptadecafluorooctane-1-sulfonic acid; [1]
potassium perfluorooctanesulfonate;
potassium heptadecafluorooctane-1-sulfonate; [2]
diethanolamine perfluorooctane sulfonate; [3]
ammonium perfluorooctane sulfonate;
ammonium heptadecafluorooctanesulfonate; [4]
lithium perfluorooctane sulfonate;
lithium heptadecafluorooctanesulfonate [5]		E217-179-8 [1]
220-527-1 [2]
274-460-8 [3]
249-415-0 [4]
249-644-6 [5]		1763-23-1 [1]
2795-39-3 [2]
70225-14-8 [3]
29081-56-9 [4]
29457-72-5 [5]		Carc. Cat. 3; R40
Repr. Cat. 2; R61
T; R48/25
Xn; R20/22
R64
N; R51-53		T; N
R: 61-20/22-40-48/25-64-51/53
S: 53-45-61
607-625-00-3clodinafop-propargyl (ISO)—105512-06-9Xn; R22-48/22
R43
N; R50-53.		Xn; N
R: 22-43-48/22-50/53
S: (2-)24-36/37-46-60-61		C ≥ 25 %: Xn, N; R22-43-48/22-50/53
10 % ≤ C < 25 %: Xn, N; R43-48/22-51/53
2,5 % ≤ C < 10 %: Xi, N; R43-51/53
0,25 % ≤ C < 2,5 %: Xi; R43-52/53
0,001 % ≤ C < 0,25 %: Xi; R43
607-626-00-9ethyl 1-(2,4-dichlorophenyl)-5-(trichloromethyl)-1 H -1,2,4-triazole-3-carboxylate401-290-5103112-35-2Carc.Cat.2; R45
N; R50-53		T; N
R: 45-50/53
S: 53-45-60-61
607-627-00-4[(4 S ,5 S )-4-benzyl-2-oxo-5-oxazolidinyl]methyl 4-nitrobenzenesulfonate416-360-0162221-28-5R43Xi
R: 43
S: (2-)22-24-37
607-628-00-X4-oxo-4-( p -tolyl)butyric acid adduct with 4-ethylmorpholine419-240-6171054-89-0Xi; R41Xi
R: 41
S: (2-)26-39
607-629-00-5[2-methyl-1-(1-oxopropoxy)propoxyphosphinyl] acetic acid419-270-1123599-82-6Xi; R36Xi
R: 36
S: (2-)26
607-630-00-0acrylic acid, 3-(trimethoxysilyl)propyl ester419-560-64369-14-6Xn; R20
C; R34
R43
R52-53		C
R: 20-34-43-52/53
S: (1/2-)26-36/37/39-45-61
607-631-00-6mixture of: 2-(2-((oxo(phenyl)acetyl)oxy)ethoxy)ethyl oxo(phenyl)acetate;
(2-(2-hydroxyethoxy)ethyl) oxo(phenyl)acetate		442-300-8—R43Xi
R: 43
S: (2-)24-37
607-632-00-1N -[3-(2,4-di-(1,1-dimethyl-propyl)phenoxy)-propyl]-1-hydroxy-5-(2-methylpropyl-oxycarbonylamino)-naphthamide420-210-1111244-14-5R53R: 53
S: 61
607-633-00-7trisodium 5-{[4-chloro-6-(1-naphthylamino)-1,3,5-triazin-2-yl]amino}-4-hydroxy-3-[( E )-(4-methoxy-2-sulfonatophenyl)diazenyl]-2,7-naphthalenedisulfonate440-480-2341026-59-3Xi; R41
R43		Xi
R: 41-43
S: (2-)22-24-26-37/39
607-634-00-2( S )-(-)-2-acetoxypropionylchloride;
(1 S )-2-chloro-1-methyl-2-oxoethyl acetate		420-610-436394-75-9Xn; R22
C; R34
R43		C
R: 22-34-43
S: (1/2-)23-26-36/37/39-45
607-635-00-8trisodium N -(3-propionato)-L-aspartate422-090-4172737-80-3Xi; R41Xi
R: 41
S: (2-)26-39
607-636-00-31-bromo-2-methylpropyl propionate422-900-6158894-67-8R10
Carc.Cat.3; R40
C; R34
R43		C
R: 10-34-40-43
S: (1/2-)7/9-8-23-26-36/37/39-45
607-637-00-9disodium 8-amino-5-{4-[2-(sulfonatoethoxy)sulfonyl]phenylazo}naphthalene-2-sulfonate423-730-5250688-43-8Xi; R41Xi
R: 41
S: (2-)26-39
607-638-00-42-hydroxybenzoic acid 2-butyloctyl ester431-090-3190085-41-7R53R: 53
S: 61
607-639-00-X2-(2-oxo-5-(1,1,3,3-tetramethylbutyl)-2,3-dihydro-1-benzofuran-3-yl)-4-(1,1,3,3-tetramethylbutyl)phenyl acetate431-770-1216698-07-6R53R: 53
S: 61
607-641-00-02-(formylamino)-3-thiophenecarboxylic acid;
2-formamido-3-thiophenecarboxylic acid		431-930-943028-69-9Xn; R22
R43		Xn
R: 22-43
S: (2-)22-24-37
607-642-00-63,6,9-trithiaundecamethylene-1,11-dimethacrylate432-210-7141631-22-3N; R50-53N
R: 50/53
S: 60-61
607-643-00-1dimethyl (2 S )-2-hydroxysuccinate432-310-0617-55-0R10
Xi; R41
R43		Xi
R: 10-41-43
S: (2-)24-26-37/39-43
607-644-00-7methyl 2,2-dimethyl-6-methylenecyclohexanecarboxylate432-350-981752-87-6Xi; R38Xi
R: 38
S: (2-)37
607-645-00-2tetrasodium 2-(4-fluoro-6-(methyl-(2-(sulfatoethylsulfonyl)ethyl)amino)-1,3,5-triazin-2-ylamino)-5-hydroxy-6-(4-methyl-2-sulfonatophenylazo)naphthalene-1,7-disulfonate432-550-6243858-01-7Xi; R41Xi
R: 41
S: (2-)22-26-39
607-646-00-8D-erythro-hexanoic acid 2,4-dideoxy-3,5- O -(1-methylethylidene)-1,1-dimethylethylester;
tert -butyl 2-[(4 R ,6 S )-6-(hydroxymethyl)-2,2-dimethyl-1,3-dioxan-4-yl]acetate		432-960-5124655-09-0Xn; R22Xn
R: 22
S: (2-)25
607-647-00-35-acetoxy-2-( R,S )butyryloxymethyl-1,3-oxathiolane433-530-1143446-73-5Xn; R22
R43
N; R50		Xn; N
R: 22-43-50
S: (2-)24-37-57-61
607-649-00-4[3-(chlorocarbonyl)-2-methylphenyl]acetate433-690-0167678-46-8C; R35
R43		C
R: 35-43
S: (1/2-)7/8-26-36/37/39-45
607-650-00-X2-methyl-1,5-pentanediamine-1,3-benzenedicarboxylate433-910-5145153-52-2R43Xi
R: 43
S: (2-)24-37
607-651-00-5sodium 2-(nonanoyloxy)benzenesulfonate434-360-991125-43-8Xi; R41
R43		Xi
R: 41-43
S: (2-)24-26-37/39
607-652-00-0ethyl N 2 -dodecanoyl-L-argininate hydrochloride434-630-660372-77-2Xi; R41
N; R50		Xi; N
R: 41-50
S: (2-)26-39-61
607-653-00-6tetrakis(bis(2-hydroxyethyl)methylammonium) 3-(4-(7-acetylamino-1-hydroxy-3-sulfonatonaphthalen-2-ylazo)-5-methoxy-2-sulfonatophenylazo)-7-(4-amino-3-sulfonatophenylamino)-4-hydroxynaphthalene-2-sulfonate434-840-8225786-91-4N; R51-53N
R: 51/53
S: 61
607-654-00-1( S )-3-hydroxy-γ-butyrolactone434-990-47331-52-4R43Xi
R: 43
S: (2-)23-24-37
607-655-00-7ethyl 6,8-dichlorooctanoate435-080-11070-64-0R43
N; R51-53		Xi; N
R: 43-51/53
S: (2-)24-37-61
607-656-00-2sodium salt of 4-amino-3,6-bis[[5-[[4-chloro-6-[(2-methyl-4-sulfophenyl)amino]-1,3,5-triazin-2-yl]amino]-2-sulfophenyl]azo]-5-hydroxy-2,7-naphthalenedisulfonic acid435-350-7141250-43-3Xi; R41
R52-53		Xi
R: 41-52/53
S: (2-)22-26-39-61
607-657-00-8pentasodium 7-(4-(4-(3-(2-sulfatoethanesulfonyl)phenylamino)-6-(4-(2-sulfatoethanesulfonyl)phenylamino)-1,3,5-triazin-2-ylamino)-2-ureidophenylazo)naphthalene-1,3,6-trisulfonate436-920-8172399-10-9Xi; R41Xi
R: 41
S: (2-)22-26-39
607-658-00-33,10-diamino-6,13-dichloro-2-((6-(((4-(1,1-dimethylethyl)phenyl)sulfonyl)amino)-2-naphthalenyl)sulfonyl)-4,11-triphenodioxazinedisulfonic acid, lithium potassium sodium salt440-770-9371921-63-0Xi; R41
R52-53		Xi
R: 41-52/53
S: (2-)26-39-61
607-659-00-9pentasodium N -[5-[[4-[[3-[(aminocarbonyl)amino]-4-[(3,6,8-trisulfonatonaphthalen-2-yl)azo]phenyl]amino]-6-chloro-1,3,5-triazin-2-yl]amino]-2-sulfonato-4-[[4-[[-2-(oxysulfonato)ethyl] sulfonyl]phenyl]azo]phenyl]-3-aminopropanoic acid442-030-0321912-47-4Xi; R41Xi
R: 41
S: (2-)22-26-39
607-660-00-42-{4-[4-[4-fluoro-6-(2-(2-vinylsulfonylethoxy)ethylamino)-1,3,5-triazin-2-ylamino]phenylazo]phenylazo}naphthalene-4,6,8-trisulfonate, trisodium salt442-230-8321679-52-1Xi; R41Xi
R: 41
S: (2-)22-26-39
607-661-00-X1,1-dimethylethyl 4′-(bromomethyl)biphenyl-2-carboxylate442-850-9114772-40-6R43
R53		Xi
R: 43-53
S: (2-)22-24-37-61
607-662-00-5methyl 2-(acetylamino)-3-chloropropionate442-860-387333-22-0R43
N; R50-53		Xi; N
R: 43-50/53
S: (2-)24-37-60-61
607-663-00-0bis(2-ethylhexyl) naphthalene-2,6-dicarboxylate442-980-6127474-91-3R53R: 53
S: 61
607-664-00-6methyl 2-chlorosulfonyl-4-(methanesulfonylaminomethyl) benzoate443-120-2393509-79-0Xi; R41
N; R51-53		Xi; N
R: 41-51/53
S: (2-)26-39-61
607-665-00-1trans -methyl-2-ethyl-but-2-enoate443-150-6101226-85-1R10R: 10
S: 23
607-666-00-7(2 S )-5-(benzyloxy)-2-(1,3-dioxo-1,3-dihydro-2 H -isoindol-2-yl)-5-oxopentanoic acid443-560-588784-33-2Xi; R36Xi
R: 36
S: (2-)26
607-667-00-2chloro-1-ethylcyclohexyl carbonate444-950-899464-83-2Muta.Cat.3; R68
R43		Xn
R: 43-68
S: (2-)23-36/37
607-668-00-8trans -2-isopropyl-5-carboxy-1,3-dioxane445-770-242031-28-7Xi; R41
R52-53		Xi
R: 41-52/53
S: (2-)22-26-39-61
607-669-00-3methyl (9-acetoxy-3,8,10-triethyl-7,8,10-trimethyl-1,5-dioxa-9-aza-spiro[5.5]undec-3-yl)octadecanoate445-990-9376588-17-9R43
R53		Xi
R: 43-53
S: (2-)24-37-61
607-670-00-9dibutyl-3-(4-(5-ammonio-2-butyl)benzofuran-3-yl)carbonyl)phenoxy)propyl ammonium oxalate;
(5-amino-2-butylbenzofuran-3-yl) [4-(3-dibutylaminopropoxy)phenyl]methanone, dioxalate		448-700-9500791-70-8Xn; R48/22
Xi; R41
R43
N; R50-53		Xn; N
R: 41-43-48/22-50/53
S: (2-)22-26-36/37/39-60-61		C ≥ 10 %: Xn, N; R41-43-48/22-50/53
5 % ≤ C < 10 %: Xi, N; R36-43-50/53
2,5 % ≤ C < 5 %: Xi, N; R43-50/53
1 % ≤ C < 2,5 %: Xi, N; R43-51/53
0,25 % ≤ C < 1 %: N; R51/53
0,025 % ≤ C < 0,25 %: R52/53
607-671-00-4diethyl 1,4-cyclohexanedicarboxylate417-310-072903-27-6N; R51-53N
R: 51/53
S: 61
607-672-00-Xmixture of: 2-hydroxy-3-(methacryloyloxy)propyl (2-benzoyl)benzoate;
1-hydroxymethyl-2-(methacryloyloxy)ethyl (2-benzoyl)benzoate;
x-hydroxy-y-(methacryloyloxy)propyl(or -ethyl) (2-benzoyl)benzoate		419-000-0—R43
N; R51-53		Xi; N
R: 43-51/53
S: (2-)24-37-61
607-673-00-51-ethyl-5,6,7,8-tetrahydroquinolinium tosylate419-570-0—Xn; R22
R52-53		Xn
R: 22-52/53
S: (2-)61
607-674-00-0branched C 10 -alkyl benzoates421-090-1131298-44-7Xn; R20Xn
R: 20
S: (2-)23
607-675-00-6mixture of: cis -9-octadecenedioic acid;
cis -9- cis -12-octadecadienedioic acid;
hexadecanedioic acid;
octadecanedioic acid		422-260-8—Xi; R41
N; R50-53		Xi; N
R: 41-50/53
S: (2-)26-39-60-61
607-676-00-1mixture of: 2-methylnonanedioic acid;
2,4-dimethyl-4-methoxycarbonylundecanedioic acid;
2,4,6-trimethyl-4,6-dimethoxycarbonyltridecanedioic acid;
8,9-dimethyl-8,9-dimethoxycarbonylhexadecanedioic acid		423-670-1—Xi; R41
R43		Xi
R: 41-43
S: (2-)24-26-37/39
607-677-00-72,5-dioxopyrrolidin-1-yl N -{[methyl[[2-(1-methylethyl)-4-thiazolyl]methyl]amino]carbonyl}-L-valinate424-660-8—Xn; R48/22
Xi; R41
R43		Xn
R: 41-43-48/22
S: (2-)22-26-36/37/39
607-678-00-2mixture of: ethyl (2 R ,3 R )-3-isopropylbicyclo[2.2.1]hept-5-ene-2-carboxylate;
ethyl (2 S ,3 S )-3-isopropylbicyclo[2.2.1]hept-5-ene-2-carboxylate		427-090-8—R43
N; R51-53		Xi; N
R: 43-51/53
S: (2-)23-25-36/37-61
607-679-00-8mixture of: 3-{5-[3-(4-{1,6-dihydro-2-hydroxy-4-methyl-1-[3-(methylammonio)propyl]-6-oxo-3-pyridylazo}benzamido)phenylazo]-1,2-dihydro-6-hydroxy-4-methyl-2-oxo-1-pyridyl}propyl(methyl)ammonium di(acetate);
3-{5-[4-(3-{1,6-dihydro-2-hydroxy-4-methyl-1-[3-(methylammonio)propyl]-6-oxo-3-pyridylazo}benzamido]phenylazo]-1,2-dihydro-6-hydroxy-4-methyl-2-oxo-1-pyridyl}propyl(dimethyl)ammonium di(acetate);
3-{5-[3-(4-{1-[3-(dimethylammonio)propyl]-1,6-dihydro-2-hydroxy-4-methyl-6-oxo-3-pyridylazo}benzamido)phenylazo]-1,2-dihydro-6-hydroxy-4-methyl-2-oxo-1-pyridyl}propyl(dimethyl)ammonium di(acetate)		431-440-5—Xi; R41
N; R51-53		Xi; N
R: 41-51/53
S: (2-)22-26-39-61
607-680-00-3tert -butyl(6-{2-[4-(4-fluorophenyl)-6-isopropyl-2-[methyl(methylsulfonyl)amino]pyrimidin-5-yl]vinyl}(4 S ,6 S )-2,2-dimethyl[1,3]dioxan-4-yl)acetate432-810-9—R53R: 53
S: 61
607-681-00-9mixture of: 9-nonyl-10-octyl-19-carbonyloxyhexadecylnonadecanoic acid;
9-nonyl-10-octyl-19-carbonyloxyoctadecylnonadecanoic acid;
dihexadecyl 9-nonyl-10-octylnonadecandioate;
1-octadecyl,19-hexadecyl 9-nonyl-10-octylnonadecandioate;
dioctadecyl 9-nonyl-10-octylnonadecandioate		432-910-2—R53R: 53
S: 61
607-682-00-4complex mixture of Chinese gum rosin post reacted with acrylic acid434-230-1144413-22-9R53R: 53
S: 61
607-683-00-Xmixture of: methyl 3-((1 E )-2-methylprop-1-enyl)-2,2-dimethylcyclopropanecarboxylate;
methyl 3-((1 Z )-2-methylprop-1-enyl)-2,2-dimethylcyclopropanecarboxylate (20:80)		435-450-0—R43
N; R51-53		Xi; N
R: 43-51/53
S: (2-)24-37-61
607-684-00-5alkenes, C 12-14 , hydroformylation products, distn. residues, C-(hydrogen sulfobutanedioates), disodium salts435-660-2243662-67-1Xi; R38
R43		Xi
R: 38-43
S: (2-)24-37
607-685-00-0ammonium 2-cocoyloxyethanesulfonate441-050-7—Xi; R38-41Xi
R: 38-41
S: (2-)26-37/39
607-686-00-66,6′-bis(diazo-5,5′,6,6′-tetrahydro-5,5′-dioxo)[methylene-bis(5-(6-diazo-5,6-dihydro-5-oxo-1-naphthylsulphonyloxy)-6-methyl-2-phenylene]di(naphthalene-1-sulfonate)441-550-5—E; R2
F; R11
Carc. Cat. 3; R40		E; Xn
R: 2-11-40
S: (2-)7-22-36/37
607-687-00-1mixture of: 2-{3,6-bis-[(2-ethylphenyl)-methylamino]-xanthylium-9-yl}-benzenesulfonate (2-10 %);
2-{3,6-bis-[(2,3-dimethylphenyl)-methylamino]-xanthylium-9-yl}-benzenesulfonate (2-10 %);
2-{3,6-bis-[(2,4-dimethylphenyl)-methylamino]-xanthylium-9-yl}-benzenesulfonate (2-10 %);
2-{3,6-bis-[(2,5-dimethylphenyl)-methylamino]-xanthylium-9-yl}-benzenesulfonate (2-10 %);
2-{3-[(2,3-dimethylphenyl)-methylamino]-6-[(2-ethylphenyl)-methylamino]-xanthylium-9-yl}-benzenesulfonate (7-20 %);
2-{3-[(2,4-dimethylphenyl)-methylamino]-6-[(2-ethylphenyl)-methylamino]-xanthylium-9-yl}-benzenesulfonate (7-20 %);
2-{3-[(2,5-dimethylphenyl)-methylamino]-6-[(2-ethylphenyl)-methylamino]-xanthylium-9-yl}-benzenesulfonate (7-20 %);
2-{3-[(2,3-dimethylphenyl)-methylamino]-6-[(2,4-dimethylphenyl)-methylamino]-xanthylium-9-yl}-benzenesulfonate (7-20 %);
2-{3-[(2,3-dimethylphenyl)-methylamino]-6-[(2,5-dimethylphenyl)-methylamino]-xanthylium-9-yl}-benzenesulfonate (7-20 %);
2-{3-[(2,4-dimethylphenyl)-methylamino]-6-[(2,5-dimethylphenyl)-methylamino]-xanthylium-9-yl}-benzenesulfonate (7-20 %)		442-800-6—Xi; R38
N; R51-53		Xi; N
R: 38-51/53
S: (2-)37-61
607-688-00-7( R )-1-cyclohexa-1,4-dienyl-1-methoxycarbonyl-methylammoniumchloride444-320-2—Xn; R22Xn
R: 22
S: (2-)
607-689-00-2mixture of: methyl 1,4-dimethylcyclohexanecarboxylate (‘para-isomer’ including cis - and trans - isomers);
methyl 1,3-dimethylcyclohexanecarboxylate (‘meta-isomer’ including cis - and trans -isomers)		444-920-4—R52-53R: 52/53
S: 61
607-690-00-8dimethyl[2 S ,2 S′ ]-6,6,6′6′-tetramethoxy-2,2′-[ N,N′ -bis(trifluoracetyl)- S,S′ -bi( L -homocysteinyl) diimino]dihexanoate432-860-1255387-46-3R43Xi
R: 43
S: (2-)24-37
607-691-00-3magnesium salts, fatty acids, C 16-18 and C 18 unsaturated, branched and linear448-690-6—R53R: 53
S: 61
607-692-00-9zinc salts, fatty acids, C 16-18 and C 18 unsaturated, branched and linear446-470-4—R53R: 53
S: 61
607-693-00-4hexyl 2-(1-(diethylaminohydroxyphenyl)methanoyl)benzoate443-860-6302776-68-7R53R: 53
S: 61
607-694-00-Xethyl 5,5-diphenyl-2-isoxazoline-3-carboxylate443-870-0163520-33-0Xn; R22
R43
N; R50-53		Xn; N
R: 22-43-50/53
S: (2-)22-36/37-60-61
608-042-00-7( S )-2,2-diphenyl-2-(3-pyrrolidinyl)acetonitrile hydrobromide421-810-4194602-27-2Xn; R22
Xi; R41
R43
N; R51-53		Xn; N
R: 22-41-43-51/53
S: (2-)24-26-37/39-61
608-059-00-X5-amino-1-(2,6-dichloro-4-(trifluoromethyl)phenyl)-1 H -pyrazole-3-carbonitrile421-240-6120068-79-3N; R51-53N
R: 51/53
S: 22-61
608-060-00-55-methyl-2-[(2-nitrophenyl)amino]-3-thiophenecarbonitrile421-300-1138564-59-7N; R50-53N
R: 50/53
S: 22-60-61
608-062-00-62-fluoro-4-hydroxybenzonitrile422-810-782380-18-5Xn; R22
Xi; R41
N; R51-53		Xn; N
R: 22-41-51/53
S: (2-)22-26-39-61
608-063-00-1( S )-α-hydroxy-3-phenoxy-benzeneacetonitrile441-070-661826-76-4T; R25
Xi; R41
R43
N; R50-53		T; N
R: 25-41-43-50/53
S: (1/2-)9-26-36/37/39-45-60-61
608-064-00-7cyanomethyltrimethylammoniummethylsulfate433-720-2—R52-53R: 52/53
S: 61
609-069-00-7musk ketone;
3,5-dinitro-2,6-dimethyl-4- tert -butylacetophenone;
4′- tert -butyl-2′,6′-dimethyl-3′,5′-dinitroacetophenone		201-328-981-14-1Carc. Cat. 3; R40
N; R50-53		Xn; N
R: 40-50/53
S: (2-)36/37-46-60-61
611-154-00-9trisodium 5-benzamido-4-hydroxy-3-(4-methyl-2-sulfonatophenylazo)naphthalene-2,7-disulfonate403-670-692408-46-3R52-53R: 52/53
S: 61
611-155-00-44,4′-oxybis(benzenesulfonylazide)431-850-47456-68-0E; R3
F; R11
Xn; R48/22
N; R50-53		E; Xn; N
R: 3-11-48/22-50/53
S: (2-)14-22-33-35-36-60-61
611-156-00-Xtriammonium 4-[4-[7-(4-carboxylatoanilino)-1-hydroxy-3-sulfonato-2-naphthylazo]-2,5-dimethoxyphenylazo]benzoate432-270-4221354-37-6Repr. Cat. 3; R62
Xn; R48/22
N; R51-53		Xn; N
R: 48/22-62-51/53
S: (2-)36/37-61
611-157-00-5benzenesulfonic acid, 3,3′-(methylenebis((dihydroxyphenylene)azo))bis-, potassium sodium salt;
potassium sodium 3-[( E )-(6-{3,4-dihydroxy-2-[( Z )-(3-sulfonatophenyl)diazenyl]benzyl}-2,3-dihydroxyphenyl)diazenyl]benzenesulfonate		432-590-4243869-48-9Xi; R36
R52-53		Xi
R: 36-52/53
S: (2-)26-61
611-158-00-0reaction mixture of: 2,3,4,2′,3′,4′-hexahydroxy-5,5′-diacethyl-diphenylmethane and 6-diazo-5,6-dihydro-5-oxo-1-naphthalenesulfonylchloride and 3-diazo-3,4-dihydro-6-methoxy-4-oxo-1-naphthalenesulfonylchloride421-520-8—F; R11
R53		F
R: 11-53
S: (2-)3-12-16-33-61
611-159-00-6disodium 4-amino-6-((4-((4-(2,4-diaminophenyl)azo)phenylsulfamoyl)phenyl)azo)-5-hydroxy-3-((4-nitrophenyl)azo)naphthalene-2,7-disulfonate421-880-6—Xi; R41
R52-53		Xi
R: 41-52/53
S: (2-)26-39-61
611-160-00-1mixture of: 1,1,1-tris(phenyl-4′-(3″-diazo-3″,4″-dihydro-4″-oxo-naphthalene-1″-sulfonato)ethane;
1,1,1-tris(phenyl-4′-(6″-diazo-5″,6″-dihydro-5″-oxo-naphthalene-1″-sulfonato)ethane;
reaction product of 1,1,1-tris( p -hydroxyphenyl)ethane with 6-diazo-5,6-dihydro-5-oxo-1-naphthylsulfonylchloride and 3-diazo-3,4-dihydro-4-oxo-1-naphthylsulfonylchloride (2:1);
reaction product of 1,1,1-tris( p -hydroxyphenyl)ethane with 6-diazo-5,6-dihydro-5-oxo-1-naphthylsulfonylchloride and 3-diazo-3,4-dihydro-4-oxo-1-naphthylsulfonylchloride (1:2)		422-760-6—F; R11
R53		F
R: 11-53
S: (2-)3-12-33-61
611-161-00-7trisodium [1,2′-(2-(8-amino-3,5-disulfonatonaphthalene)azo)-(4′-nitrobenzene)diolato- O,O,N ][( Z )-2,2-((phenylcarbamoylprop-1′-enyl)azo)-5-sulfamoylbenzene)diolato- O,O,N ]chromate(III)423-100-1—Xi; R41Xi
R: 41
S: (2-)26-39
611-162-00-22,4-bis(((2-(dimethylammonio)ethyloxy)carbonyl)phen-2-ylazo)benzene-1,3-diolbis(methanesulfonate)429-600-4—Xn; R22
Xi; R41
N; R51-53		Xn; N
R: 22-41-51/53
S: (2-)22-26-39-61
611-163-00-82,4-bis(((2-(dimethylammonio)ethyloxy)carbonyl)phen-2-ylazo)benzene-1,3-diol sulfate429-610-9—Xn; R22
Xi; R41
N; R51-53		Xn; N
R: 22-41-51/53
S: (2-)22-26-39-61
611-164-00-3mixture of: 2,2′-dimethyl-2,2′-azobutanenitrile;
2-methylpentanenitrile-2-azo-2′-(2′-methylpropanenitrile);
2,2′-dimethyl-2,2′-azoheptanenitrile;
2-methylheptanenitrile-2-azo-2′-(2′-methylpropanenitrile);
2-methylheptanenitrile-2-azo-2′-(2′-methylbutanenitrile)		429-710-2—R10
R32
R44
Xn; R22
N; R51-53		Xn; N
R: 10-22-32-44-51/53
S: (2-)12-15-16-47-51-61
611-165-00-9mixture of: tetrasodium 4-amino-6-(5-(2,6-difluoropyrimidin-4-ylamino)-2-sulfonatophenylazo)-5-hydroxy-3-(4-(sulfatoethylsulfonyl)phenylazo)naphthalene-2,7-disulfonate;
tetrasodium 4-amino-6-(5-(4,6-difluoropyrimidin-2-ylamino)-2-sulfonatophenylazo)-5-hydroxy-3-(4-(2-sulfatoethylsulfonyl)phenylazo)naphthalene-2,7-disulfonate		431-830-5—R52-53R: 52/53
S: 61
611-166-00-4mixture of: pentasodium 4-amino-5-hydroxy-3-{( E )-4-[2-(sulfonatooxy)ethylsulfonyl]phenylazo}-6-{( E )-2-sulfonato-4-[2-(sulfonatooxy)ethylsulfonyl]phenylazo}naphthalene-2,7-disulfonate;
tetrasodium 4-amino-5-hydroxy-3-{( E )-4-[2-(sulfonatooxy)ethylsulfonyl]phenylazo}-6-[( E )-2-sulfonato-4-(vinylsulfonyl)phenylazo]naphthalene-2,7-disulfonate;
tetrasodium 4-amino-5-hydroxy-6-{( E )-2-sulfonato-4-[2-(sulfonatooxy)ethylsulfonyl]phenylazo}-3-[( E )-4-(vinylsulfonyl)phenylazo]naphthalene-2,7-disulfonate		432-100-9—Xi; R41
R52-53		Xi
R: 41-52/53
S: (2-)26-39-61
611-167-00-Xsodium bis[tris(2-hydroxyethyl)ammonium][6-anilino-4′-(4,8-disulfonato-2-naphthylazo)-5′-methyl-3-sulfonatonaphthalene-2-azobenzene-1,2′-diolato]cuprate(II)435-240-9—R52-53R: 52/53
S: 61
611-168-00-5mixture of: 3-[[4-chloro-6-[[7-[(1,5-disulfo-2-naphthalenyl)azo]-8-hydroxy-3,6-disulfo-1-naphthalenyl]amino]-1,3,5-triazin-2-yl]amino]-5-[[4-chloro-6-[[8-hydroxy-3,6-disulfo-7-[(2-sulfophenyl)azo]-1-naphthalenyl]amino]-1,3,5-triazin-2-yl]amino]benzoic acid;
3,5-bis[[4-chloro-6-[[7-[(1,5-disulfo-2-naphthalenyl)azo]-8-hydroxy-3,6-disulfo-1-naphthalenyl]amino]-1,3,5-triazin-2-yl]amino]benzoic acid		435-440-6—Xi; R41Xi
R: 41
S: (2-)22-26-39
611-169-00-0sodium 5-(2-carboxyphenylazo)-6-hydroxynaphthalene-2-sulfonate435-800-2—R52-53R: 52/53
S: 61
611-170-00-6mixture of: trisodium 2-((1-(2-hydroxy-κ- O -5-(2-sulfonatoethansulfonyl)phenylazo-κ- N 2 )-1-phenylmethyl)azo-κ- N 1 )-4-sulfonatobenzoate(5-)-κ- O )cuprate(II);
disodium 2-((1-(5-ethenesulfonyl-2-hydroxy-κ- O -phenylazo-κ- N 2 )-1-phenylmethyl)azo-κ- N 1 )-4-sulfonatobenzoate-κ- O -(5-))cuprate(II)		435-880-9—R52-53R: 52/53
S: 22-61
611-171-00-1mixture of: trisodium 3-(5-(2,6-difluoropyrimidin-4-ylamino)-2-sulfonatophenylazo)-5-(4-fluoro-6-morpholin-4-yl-1,3,5-triazin-2-ylamino)-4-hydroxy-2,7-naphthalenedisulfonate;
trisodium 3-(5-(4,6-difluoropyrimidin-2-ylamino)-2-sulfonatophenylazo)-5-(4-fluoro-6-morpholin-4-yl-1,3,5-triazin-2-ylamino)-4-hydroxy-2,7-naphthalenedisulfonate		436-890-6—Xi; R41
R52-53		Xi
R: 41-52/53
S: (2-)22-26-39-61
611-172-00-7mixture of: triammonium 6-amino-3-((2,5-diethoxy-4-(3-phosphonophenyl)azo)phenyl)azo-4-hydroxy-2-naphthalenesulfonate;
diammonium 3-((4-((7-amino-1-hydroxy-3-sulfo-naphthalen-2-yl)azo)-2,5-diethoxyphenyl)azo)benzoate		438-310-7—E; R2
Repr. Cat. 3; R62
Xn; R22-48/22
R52-53		E; Xn
R: 2-22-48/22-62-52/53
S: (2-)22-35-36/37-61
611-173-00-2mixture of: 3-[3-carbamoyl-5-(5-{4-chloro-6-[4-(2-sulfonatooxyethylsulfonyl)anilino]-1,3,5-triazin-2-ylamino}-2-sulfonatophenylazo)-1,2-dihydro-6-hydroxy-4-methyl-2-oxo-1-pyridyl]propanoic acid, trisodium salt;
3-[3-carbamoyl-5-(5-{4-chloro-6-[4-(vinylsulfonyl)anilino]-1,3,5-triazin-2-ylamino}-2-sulfonatophenylazo)-1,2-dihydro-6-hydroxy-4-methyl-2-oxo-1-pyridyl]propanoic acid, disodium salt		440-510-4—Xi; R41
R43		Xi
R: 41-43
S: (2-)22-26-36/37/39
611-174-00-8mixture of: 3-[5-(4-ethenesulfonylbutyrylamino)-2-sulfophenylazo]-5-{4-chloro-[6-(4-(3-amino-5-hydroxy-2,7-disulfonaphthalene-4-ylazo)-3-sulfophenylamino]-1,3,5-triazin-2-ylamino}-4-hydroxynaphthalene-2,7-disulfonic acid, sodium salt;
3-[5-(4-(2-chloroethanesulfonyl)butyrylamino)-2-sulfophenylazo]-5-{4-chloro-[6-(4-(3-amino-5-hydroxy-2,7-disulfonaphthalene-4-ylazo)-3-sulfophenylamino]-1,3,5-triazin-2-ylamino}-4-hydroxynaphthalene-2,7-disulfonic acid, sodium salt		442-290-5457624-86-1Xi; R41Xi
R: 41
S: (2-)22-26-39
611-175-00-3mixture of: trisodium 5-{4-chloro-6-[ N -ethyl-(3-(2-sulfonatooxy)ethylsulfonyl)anilino]-1,3,5-triazin-2-ylamino}-4-hydroxy-3-[4-(vinylsulfonyl)phenylazo]naphthalene-2,7-disulfonate;
trisodium 5-{4-chloro-6-[ N -ethyl-3-(vinylsulfonyl)anilino]-1,3,5-triazin-2-ylamino}-4-hydroxy-3-[4-(2-(sulfonatooxy)ethylsulfonyl)phenylazo]naphthalene-2,7-disulfonate;
disodium 5-{4-chloro-6-[ N -ethyl-3-(vinylsulfonyl)anilino]-1,3,5-triazin-2-ylamino}-4-hydroxy-3-[(4-vinylsulfonyl)phenylazo]naphthalene-2,7-disulfonate;
tetrasodium 5-{4-chloro-6-[ N -ethyl-3-(2-(sulfonatooxy)ethylsulfonyl)anilino]-1,3,5-triazin-2-ylamino}-3-[4-(2-(sulfonatooxy)ethylsulfonyl)phenylazo]-4-hydroxynaphthalene-2,7-disulfonate		444-050-5—Xi; R41
R52-53		Xi
R: 41-52/53
S: (2-)22-26-39-61
611-176-00-92,6-bis(2,3,4-trihydroxybenzyl)- p -cresol ester with 6-diazo-5,6-dihydro-5-oxo-1-naphthalenesulfonate444-250-2—E; R2
F; R11
N; R51-53		E; N
R: 2-11-51/53
S: (2-)22-61
611-177-00-4mixture of: pentasodium bis[6-anilino-3,5′-disulfonatonaphthalene-2-azobenzene-1,2′-diolato]cobaltate(III);
tetrasodium [6-anilino-3,5′-disulfonatonaphthalene-2-azobenzene-1,2′-diolato][6-anilino-5′-sulfamoyl-3-sulfonatonaphthalene-2-azobenzene-1,2′-diolato]cobaltate(III);
trisodium bis[6-anilino-5′-sulfamoyl-3-sulfonatonaphthalene-2-azobenzene-1,2′-diolato]cobaltate(III)		444-290-0508202-43-5Xi; R41
R43
R52-53		Xi
R: 41-43-52/53
S: (2-)22-24-26-37/39-61
611-178-00-Xmixture of: pentasodium 4-amino-5-hydroxy-3-{( E )-4-[2-(sulfonatooxy)ethylsulfonyl]phenylazo}-6-{( E )-2-sulfonato-4-[2-(sulfonatooxy)ethylsulfonyl]phenylazo}naphthalene-2,7-disulfonate;
tetrasodium 4-amino-5-hydroxy-3-{( E )-4-[2-(sulfonatooxy)ethylsulfonyl]phenylazo}-6-[( E )-2-sulfonato-4-(vinylsulfonyl)phenylazo]naphthalene-2,7-disulfonate;
tetrasodium 4-amino-5-hydroxy-6-[( E )-2-sulfonato-4-[2-(sulfonatooxy)ethylsulfonyl]phenylazo}-3-[( E )-4-(vinylsulfonyl)phenylazo]naphthalene-2,7-disulfonate;
trisodium 4-amino-5-hydroxy-3-[( E )-4-(vinylsulfonyl)phenylazo]-6-[( E )-2-sulfonato-4-(vinylsulfonyl)phenylazo]naphthalene-2,7-disulfonate;
trisodium 4-amino-5-hydroxy-3-[(2-hydroxyethylsulfonyl)-phenylazo]-6-[( E )-2-sulfonato-4-(vinylsulfonyl)phenylazo]naphthalene-2,7-disulfonate;
trisodium 4-amino-5-hydroxy-3-[( E )-4-(vinylsulfonyl)phenylazo]-6-[-2-sulfonato-4-(2-hydroxyethylsulfonyl)phenylazo]naphthalene-2,7-disulfonate		445-280-9—Xi; R41
R43
R52-53		Xi
R: 41-43-52/53
S: (2-)24-26-37/39-61
611-179-00-5mixture of: pentasodium 2-[[8-[[4-chloro-6-[[4-(2-sulfonato ethylsulfonyl)]phenyl]amino]-1,3,5-triazin-2-yl]amino-1- hydroxy-3,6-disulfonato-2-naphthalenyl]azo]naphthalene-1,5-disulfonate;
2-[[8-[[4-chloro-6-[[4-[[2-ethenyl]sulfonyl]phenyl]amino]-1,3,5-triazin-2-yl]amino]-1-hydroxy-3,6-disulfonato-2-naphthalenyl]azo]naphthalene-1,5-disulfonate		450-010-8—Xi; R41
R43		Xi
R: 41-43
S: (2-)22-24-26-37/39
611-180-00-0iron, complexes with diazotised 4-aminobenzenesulfonamide,diazotised 3-aminobenzenesulfonic acid, diazotised 3-amino-4-hydroxybenzenesulfonamide,diazotised 3-amino-4-hydroxy-N-phenylbenzenesulfonamide, diazotised 5-amino-2-(phenylamino)benzenesulfonic acid and resorcinol, sodium salts417-850-7—N; R51-53N
R: 51/53
S: 22-61
612-238-00-8(3-chloro-2-hydroxypropyl) trimethylammonium chloride … %B222-048-33327-22-8Carc. Cat. 3, R40
R52-53		Xn
R: 40-52/53
S: 36/37-61
612-239-00-3biphenyl-3,3′,4,4′-tetrayltetraamine;
diaminobenzidine		202-110-691-95-2Carc. Cat. 2; R45
Muta. Cat. 3; R68		T
R: 45-68
S: 53-45
612-240-00-9pyrimethanil (ISO);
N -(4,6-dimethylpyrimidin-2-yl)aniline		—53112-28-0N; R51-53N
R: 51/53
S: 61
612-241-00-4piperazine hydrochloride; [1]
piperazine dihydrochloride; [2]
piperazine phosphate [3]		228-042-7 [1]
205-551-2 [2]
217-775-8 [3]		6094-40-2 [1]
142-64-3 [2]
1951-97-9 [3]		Repr. Cat. 3; R62-63
Xi; R36/38
R42/43
R52-53		Xn
R: 36/38-42/43-62-63-52/53
S: (1/2-)22-36/37-45-63-61
612-242-00-Xcyprodinil (ISO);
4-cyclopropyl-6-methyl- N -phenylpyrimidin-2-amine		—121552-61-2R43
N; R50-53		Xi; N
R: 43-50/53
S: (2-)24-37-46-60-61		C ≥ 2,5 %: Xi, N; R43-50/53
1 % ≤ C < 2,5 %: Xi, N; R43-51/53
0,25 % ≤ C < 1 %: N; R51/53
0,025 % ≤ C < 0,25 %: R52/53
612-243-00-5(1 S-cis )-4-(3,4-dichlorophenyl)-1,2,3,4-tetrahydro- N -methyl-1-naphthalenamine 2-hydroxy-2-phenylacetate420-560-379617-97-3Xi; R41
N; R50-53		Xi; N
R: 41-50/53
S: (2-)26-39-60-61		C ≥ 10 %: Xi, N; R41-50/53
5 % ≤ C < 10 %: Xi, N; R36-50/53
2,5 % ≤ C < 5 %: N; R50/53
0,25 % ≤ C < 2, 5 %: N; R51/53
0,025 % ≤ C < 0,25 %: R52/53
612-244-00-03-(piperazin-1-yl)-benzo[d]isothiazole hydrochloride421-310-687691-88-1Repr. Cat. 3; R62
Xn; R22
Xi; R36
R43
N; R50-53		Xn; N
R: 22-36-43-62-50/53
S: (2-)22-26-36/37/39-60-61
612-245-00-62-ethylphenylhydrazine hydrochloride421-460-219398-06-2Carc. Cat. 3; R40
T; R48/25
Xn; R22
Xi; R41
R43
N; R50-53		T; N
R: 22-40-41-43-48/25-50/53
S: (1/2-)22-26-36/37/39-45-60-61		C ≥ 25 %: T, N; R22-40-41-43-48/25-50/53
10 % ≤ C < 25 %: T, N; R40-41-43-48/25-50/53
5 % ≤ C < 10 %: Xn, N; R36-40-43-48/22-50/53
2,5 % ≤ C < 5 %: Xn, N; R40-43-48/22-50/53
1 % ≤ C < 2,5 %: Xn, N; R40-43-48/22-51/53
0,25 % ≤ C < 1 %: N; R51/53
0,025 % ≤ C < 0,25 %: R52/53
612-246-00-1(2-chloroethyl)(3-hydroxypropyl)ammonium chlorideE429-740-640722-80-3Carc. Cat. 2; R45
Muta. Cat. 2; R46
Xn; R48/22
R43
R52-53		T
R: 45-46-43-48/22-52/53
S: 53-45-61
612-247-00-7N -[3-(1,1-dimethylethyl)-1 H -pyrazol-5-yl]- N′ -hydroxy-4-nitrobenzenecarboximidamide423-530-8152828-23-4T; R48/25
Xn; R22
R52-53		T
R: 22-48/25-52/53
S: (1/2-)22-36-45-61
612-248-00-2reaction product of diphenylamine, phenothiazine, and alkenes, branched (C 8-10 , C 9 -rich)439-540-0—Xi; R38
R43
R53		Xi
R: 38-43-53
S: (2-)24-37-61
612-249-00-84-[(3-chlorophenyl)(1 H -imidazol-1-yl)methyl]-1,2-benzenediamine dihydrochloride425-030-5159939-85-2Repr. Cat. 3; R62
Xn; R22
C; R34
R43
N; R51-53		C; N
R: 22-34-43-62-51/53
S: (1/2-)22-26-36/37/39-45-61
612-250-00-3chloro- N,N -dimethylformiminium chlorideE425-970-63724-43-4R14
Repr. Cat. 2; R61
Xn; R22
C; R35		T; C
R: 61-14-22-35
S: 53-45
612-251-00-9cis -1-(3-chloroallyl)-3,5,7-triaza-1-azoniaadamantane chloride426-020-351229-78-8F; R11
Repr. Cat. 3; R63
Xn; R22
Xi; R38
R43
N; R51-53		F; Xn; N
R: 11-22-38-43-63-51/53
S: (2-)7-22-33-36/37-61
612-252-00-4imidacloprid (ISO);
1-(6-chloropyridin-3-ylmethyl)- N -nitroimidazolidin-2-ylidenamine		428-040-8138261-41-3Xn; R22
N; R50-53		Xn; N
R: 22-50/53
S: (2-)22-57-60-61
612-253-00-X7-methoxy-6-(3-morpholin-4-yl-propoxy)-3 H -quinazolin-4-one;
[containing < 0,5 % formamide (EC No 200-842-0)]		429-400-7199327-61-2R52-53R: R52/53
S: 61
612-253-01-77-methoxy-6-(3-morpholin-4-yl-propoxy)-3 H -quinazolin-4-one;
[containing ≥ 0,5 % formamide (EC No 200-842-0)]		429-400-7199327-61-2Repr. Cat. 2; R61
R52-53		T
R: 61-52/53
S: 53-45-61
612-254-00-5reaction products of diisopropanolamine with formaldehyde (1:4)432-440-8220444-73-5Carc. Cat. 3; R40
Xn; R22
C; R34
R43
N; R51-53		C; N
R: 22-34-40-43-51/53
S: (1/2-)13-25-26-36/37/39-45-61
612-255-00-01-(3-methoxypropyl)-4-piperidinamine431-950-8179474-79-4Xn; R21/22
C; R34
R52-53		C
R: 21/22-34-52/53
S: (1/2-)26-36/37/39-45-61
612-256-00-6benzyl( S )-2-[(2′-cyanobiphenyl-4-ylmethyl)pentanoylamino]-3-methylbutyrate427-470-3137864-22-3Xn; R22
R43		Xn
R: 22-43
S: (2-)36/37
612-257-00-1tripropylammonium dihydrogenphosphate433-700-335687-90-2Xn; R22Xn
R: 22
S: (2-)22
612-259-00-2N -ethyl-3-trimethoxysilyl-2-methyl-propanamine437-720-3227085-51-0Xi; R41Xi
R: 41
S: (2-)26-39
612-261-00-33,5-dichloro-2-fluoro-4-(1,1,2,3,3,3-hexafluoropropoxy)aniline441-190-9121451-05-6Xn; R22
R43
N; R50-53		Xn; N
R: 22-43-50/53
S: (2-)24-37-60-61		C ≥ 25 %: Xn, N; R22-43-50/53
2,5 % ≤ C < 25 %: Xi, N; R43-50/53
1 % ≤ C < 2,5 %: Xi, N; R43-51/53
0,25 % ≤ C < 1 %: N; R51/53
0,025 % ≤ C < 0,25 %: R52/53
612-265-00-5bis(2-hydroxyethyl)-(2-hydroxypropyl)ammonium acetate444-360-0191617-13-7R52-53R: 52/53
S: 61
612-266-00-03-chloro-4-(3-fluorobenzyloxy)aniline445-590-4202197-26-0Muta. Cat. 3; R68
Xn; R22-48/22
N; R50-53		Xn; N
R: 22-48/22-68-50/53
S: (2-)22-36/37-60-61
612-267-00-6bis(hydrogenated tallow C 16-18 -alkyl)hydroxylamine418-370-0—R43
R53		Xi
R: 43-53
S: (2-)36/37-61
612-269-00-7mixture of: 1-[di(4-octylphenyl)aminomethyl]-5-methyl-1 H -benzotriazole;
1-[di(4-octylphenyl)aminomethyl]-4-methyl-1 H -benzotriazole;
mixture of: N -[(5-methyl-1 H -benzotriazol-1-yl)methyl]-4-octyl- N -(4-octylphenyl)aniline;
N -[(4-methyl-1 H -benzotriazol-1-yl)methyl]-4-octyl- N -(4-octylphenyl)aniline		420-720-2—R53R: 53
S: 22-61
612-270-00-2( S )-azetidine-2-carboxylic acid 4-cyanobenzylamide hydrochloride433-010-2—Xn; R22
R43
R52-53		Xn
R: 22-43-52/53
S: (2-)22-36/37-61
612-271-00-8mixture of: ethyl 2-((4-(5,6-dichlorobenzothiazol-2-ylazo)phenyl)ethylamino)benzoate;
ethyl 2-((4-(6,7-dichlorobenzothiazol-2-ylazo)phenyl)ethylamino)benzoate		434-970-5160987-57-5R53R: 53
S: 61
612-272-00-3ammonium (η-6-2-(2-(1,2-dicarboxylatoethylamino)ethylamino)butane-1,4-dioato(4-))iron(3+) monohydrate435-210-5—N; R51-53N
R: 51/53
S: 61
612-273-00-9alkyl(rapeseed oil), bis(2-hydroxyethyl)ammonium fluoride435-650-8—Xn; R22
C; R35
N; R50-53		C; N
R: 22-35-50/53
S: (1/2-)26-36/37/39-45-60-61
612-274-00-4( R,S )-1-[2-amino-1(4-methoxyphenyl)ethyl]cyclohexanol acetate445-750-3—Xn; R22
Xi; R41
R43
R52-53		Xn
R: 22-41-43-52/53
S: (2-)22-24-26-37/39-61
612-275-00-Xfatty acids, C 18 -unsatd., dimers, reaction products with 1-piperazineethanamine and tall oil447-880-6206565-89-1Xi; R38-41
R43
N; R50-53		Xi; N
R: 38-41-43-50/53
S: (2-)23-26-36/37/39-60-61		C ≥ 20 %: Xi, N; R38-41-43-50/53
10 % ≤ C < 20 %: Xi, N; R41-43-50/53
5 % ≤ C < 10 %: Xi, N; R36-43-50/53
2,5 % ≤ C < 5 %: Xi, N; R43-50/53
1 % ≤ C < 2,5 %: Xi, N; R43-51/53
0,25 % ≤ C < 1 %: N; R51/53
0,025 % ≤ C < 0,25 %: R52/53
612-276-00-51-amino-4-[(4-amino-2-sulfofenyl)amino]-9,10-dihydro-9,10-dioxo-2-anthracenesulfonic acid, disodium salt, reaction products with 2-[[3-[(4,6-dichloro-1,3,5-triazin-2-yl)ethylamino]phenyl]sulfonyl]ethyl hydrogen sulfate, sodium salts451-430-4500717-36-2Xi; R41
R43
R52-53		Xi
R: 41-43-52/53
S: (2-)22-24-26-36/37/39-61
612-277-00-0mixture of: 4-amino-3-(4-ethenesulfonyl-2-sulfonatophenylazo)-5-hydroxy-6-(5-{4-chloro-6-[4-(2-sulfonatooxyethanesulfonyl)phenylamino]-1,3,5-triazin-2-ylamino}-2-sulfonatophenylazo)naphthalene-2,7-disulfonate potassium/sodium;
4-amino-5-hydroxy-6-(5-{4-chloro-6-[4-(2-sulfonatooxyethanesulfonyl)phenylamino]-1,3,5-triazin-2-ylamino}-2-sulfonatophenylazo)-3-(2-sulfonato-4-(2-sulfonatooxyethanesulfonyl)phenylazo)naphthalene-2,7-disulfonate potassium/sodium		451-440-9586372-44-3Xi; R41Xi
R: 41
S: (2-)22-26-39
612-278-00-6ethidium bromide;
3,8-diamino-1-ethyl-6-phenylphenantridinium bromide		214-984-61239-45-8Muta. Cat. 3; R68
T+; R26
Xn; R22		T+
R: 22-26-68
S: (1/2-)28-36/37-45-63
612-279-00-1( R,S )-2-amino-3,3-dimethylbutane amide447-860-7144177-62-8Repr. Cat. 3; R62
Xn; R48/22
Xi; R36/38
R43		Xn
R: 36/38-43-48/22-62
S: (2-)22-26-36/37
612-280-00-73-amino-9-ethyl carbazole;
9-ethylcarbazol-3-ylamine		H205-057-7132-32-1Carc. Cat. 2; R45T
R: 45
S: 53-45
613-116-01-4tolylfluanid (ISO);
dichloro- N -[(dimethylamino)sulphonyl]fluoro- N -( p -tolyl)methanesulphenamide;
[containing < 0,1 % (w/w) of particles with an aerodynamic diameter of below 50 μm]		211-986-9731-27-1Xi; R36/37/38
R43
N; R50		Xi; N
R: 36/37/38-43-50
S: (2-)25-36/37-46-61		C ≥ 20 %: Xi, N; R36/37/38-43-50
2,5 % ≤ C < 20 %: Xi, N; R43-50
1 % ≤ C < 2,5 %: Xi; R43
613-280-00-Xtetrahydro-1,3-dimethyl-1 H -pyrimidin-2-one;
dimethyl propyleneurea		230-625-67226-23-5Repr. Cat. 3; R62
Xn; R22
Xi; R41		Xn
R: 22-41-62
S: 26-36/37/39
613-281-00-5quinolineE202-051-691-22-5Carc. Cat. 2; R45
Muta. Cat. 3; R68
Xn; R21/22
Xi; R36/38
N; R51-53		T; N
R: 45-21/22-36/38-68-51/53
S: 53-45-61
613-282-00-0triticonazole (ISO);
( RS )-( E )-5-(4-chlorobenzylidene)-2,2-dimethyl-1-(1 H -1,2,4-triazol-1-methyl)cyclopentanol		—131983-72-7N; R51-53N
R: 51/53
S: 61
613-283-00-6ketoconazole;
1-[4-[4-[[(2 SR ,4 RS )-2-(2,4-dichlorophenyl)-2-(imidazol-1-ylmethyl)-1,3-dioxolan-4-yl]methoxy]phenyl]piperazin-1-yl]ethanone		E265-667-465277-42-1Repr. Cat. 2; R60
T; R25
Xn; R48/22
N; R50-53		T; N
R: 60-25-48/22-50/53
S: 53-45-60-61
613-284-00-1metconazole (ISO);
(1 RS ,5 RS ;1 RS ,5 SR )-5-(4-chlorobenzyl)-2,2-dimethyl-1-(1 H -1,2,4-triazol-1-ylmethyl)cyclopentanol		—125116-23-6Repr. Cat. 3; R63
Xn; R22
N; R51-53		Xn; N
R: 22-63-51/53
S: (2-)36/37-46-61
613-285-00-71-hydroxybenzotriazole, anhydrous; [1]
1-hydroxybenzotriazole, monohydrated [2]		219-989-7 [1]
219-989-7 [2]		2592-95-2 [1]
123333-53-9 [2]		E; R2E
R: 2
S: 16-35
613-286-00-2potassium 1-methyl-3-morpholinocarbonyl-4-[3-(1-methyl-3-morpholinocarbonyl-5-oxo-2-pyrazolin-4-ylidene)-1-propenyl]pyrazole-5-olate;
[containing < 0,5 % N,N-dimethylformamide (EC No 200-679-5)]		418-260-2183196-57-8R43Xi
R: 43
S: (2-)24-37
613-286-01-Xpotassium 1-methyl-3-morpholinocarbonyl-4-[3-(1-methyl-3-morpholinocarbonyl-5-oxo-2-pyrazolin-4-ylidene)-1-propenyl]pyrazole-5-olate;
[containing ≥ 0,5 % N,N-dimethylformamide (EC No 200-679-5)]		418-260-2183196-57-8Repr. Cat. 2; R61
R43		T
R: 61-43
S: 53-45
613-287-00-81-(3-iodo-4-aminobenzyl)-1 H -1,2,4-triazole419-540-7160194-26-3Xn; R22
R43
N; R51-53		Xn; N
R: 22-43-51/53
S: (2-)24-37-61
613-288-00-31,3-bis(dimethylcarbamoyl)-imidazolium chloride420-930-4135756-61-5Xn; R22
Xi; R41
R52-53		Xn
R: 22-41-52/53
S: (2-)22-26-37/39-61
613-289-00-93-(4-chloro-2-fluoro-5-methylphenyl)-1-methyl-5-(trifluoromethyl)-1 H -pyrazole432-020-4142623-48-1N; R50-53N
R: 50/53
S: 60-61
613-290-00-44-hydroxy-7-(2-aminoethyl)-1,3-benzothiazol-2(3 H )-one hydrochloride432-470-1189012-93-9Xi; R41
R43
N; R50-53		Xi; N
R: 41-43-50/53
S: (2-)24-26-37/39-60-61
613-291-00-X2,4-dihydro-4-(4-(4-(4-hydroxyphenyl)-1-piperazinyl)phenyl)-2-(1-methylpropyl)-3 H -1,2,4-triazol-3-one434-820-9106461-41-0Xn; R48/22
N; R50-53		Xn; N
R: 48/22-50/53
S: (2-)22-36-60-61
613-292-00-5N,N′,N″ -tris(2-methyl-2,3-epoxypropyl)-perhydro-2,4,6-oxo-1,3,5-triazine435-010-826157-73-3Muta. Cat. 3; R68
R52-53		Xn
R: 68-52/53
S: (2-)36/37-61
613-293-00-02-(4- tert -butylphenyl)-6-cyano-5-[bis(ethoxycarbonylmethyl)carbamoyloxy]-1 H -pyrrolo[1,2-b][1,2,4] triazole-7-carboxylic acid 2,6-di- tert -butyl-4-methylcyclohexylester448-050-6444065-11-6R53R: 53
S: 61
613-294-00-62-hexyldecanoic acid [4-(6- tert -butyl-7-chloro-1 H -pyrazolo[1,5-b][1,2,4]triazol-2-yl)phenylcarbamoyl]methylester448-260-8379268-96-9R53R: 53
S: 61
613-295-00-111-amino-3-chloro-6,11-dihydro-5,5-dioxo-6-methyl-dibenzo[c,f][1,2]thiazepine hydrochloride448-720-8363138-44-7Xn; R22
Xi; R41
R52-53		Xn
R: 22-41-52/53
S: (2-)22-26-39-61
613-296-00-7pentapotassium 2-(4-(5-[1-(2,5-disulfonatophenyl)-4,5-dihydro-3-methylcarbamoyl-5-oxopyrazol-4-ylidene]-3-methyl-1,3-pentadienyl)-3-methylcarbamoyl-5-oxidopyrazol-1-yl)benzene-1,4-disulfonate418-270-7—R43
R52-53		Xi
R: 43-52/53
S: (2-)24-37-47-61
613-297-00-25-(2-bromophenyl)-2- tert -butyl-2 H -tetrazole420-820-6—R10
Xn; R22
N; R51-53		Xn; N
R: 10-22-51/53
S: (2-)16-61
613-298-00-8bis-(6-hydroxy-4-methyl-5-(3-methylimidazolium-1-yl)-3-(4-phenylazo)-1 H -pyridin-2-one)ethylene dilactate421-560-6—Xn; R48/22
Xi; R41
N; R51-53		Xn; N
R: 41-48/22-51/53
S: (2-)22-26-36/39-61
613-299-00-3main component 1 (isomer 1): 2-{6-fluoro-4-[3-(2,5-disulfo-phenylazo)-4-hydroxy-2-sulfonapht-7-ylamino]-1,3,5-triazin-2-ylamino}-3-{6-fluoro-4-[3-(1,5-disulfonaphth-2-ylazo)-4-hydroxy-2-sulfonaphth-7-ylamino]-1,3,5-triazin-2-ylamino}-propane sodium salt;
main component 1 (isomer 2): 2-{6-fluoro-4-[3-(2,5-disulfo-phenylazo)-4-hydroxy-2-sulfonaphth-7-ylamino]-1,3,5-triazin-2-ylamino}-3-{6-fluoro-4-[3-(2,5-disulfo-phenylazo)-4-hydroxy-2-sulfonaphth-7-ylamino]-1,3,5-triazin-2-ylamino}-propane sodium salt;
main component 2: 2,3-bis-{6-fluoro-4-[3-(2,5-disulfo-phenylazo)-4-hydroxy-2-sulfonaphth-7-ylamino]-1,3,5-triazin-2-ylamino}-propane sodium salt;
main component 3: 2,3-bis-{6-fluoro-4-[3-(1,5-disulfonaphth-2-ylazo)-4-hydroxy-2-sulfonaphth-7-ylamino]-1,3,5-triazin-2-ylamino}-propane sodium salt		422-610-1—Xi; R41Xi
R: 41
S: (2-)22-26-39
613-300-00-71-imidazol-1-yl-octadecan-2-ol434-120-3—R43
R53		Xi
R: 43-53
S: (2-)24-37-61
613-301-00-2dimethyl-1-{[2-methoxy-5-(2-methyl-butoxycarbonyl)phenylcarbamoyl]-[2-octadecyl-1,1-dioxo-1,2,4-benzothiadiazin-3-yl]methyl} imidazole-4,5-dicarboxylate443-910-7—R53R: 53
S: 61
613-302-00-8disodium 2-(5-carbamoyl-1-ethyl-2-hydroxy-4-methyl-6-oxo-1,6-dihydro-pyridine-3-ylazo)-4-(4-fluoro-6-(4-(2-sulfonyloxy-ethylsulfonyl)-phenylamino)-1,3,5-triazine-2-ylamino)benzene sulfonate432-980-4243858-60-8Xi; R41Xi
R: 41
S: (2-)22-26-39
613-303-00-32-(1-methyl-2-(4-phenoxyphenoxy)ethoxy)pyridine429-800-195737-68-1N; R50-53N
R: 50/53
S: 60-61
613-304-00-95,6-dihydroxy-2,3-dihydro-1 H -indolium bromide421-170-6138937-28-7Xn; R22
Xi; R41		Xn
R: 22-41
S: (2-)22-26-39
613-305-00-42-(2-hydroxy-4-octyloxyphenyl)-2 H -benzotriazole448-630-93147-77-1R53R: 53
S: 61
613-306-00-X(2,5-dioxopyrrolidin-1-yl)-9 H -fluoren-9-ylmethyl carbonate433-520-582911-69-1Xn; R22
R43
N; R51-53		Xn; N
R: 22-43-51/53
S: (2-)24-37-61
613-307-00-5clothianidin (ISO);
3-[(2-chloro-1,3-thiazol-5-yl)methyl]-2-methyl-1-nitroguanidine		—210880-92-5Xn; R22
N; R50-53		Xn; N
R: 22-50/53
S: (2-)46-60-61		C ≥ 25 %: Xn, N; R22-50/53
2,5 % ≤ C < 25 %: N; R50/53
0,25 % ≤ C < 2,5 %: N; R51/53
0,025 % ≤ C < 0,25 %: R52/53
613-308-00-02-amino-5-methylthiazole423-800-57305-71-7Xn; R22-48/22
N; R50-53		Xn; N
R: 22-48/22-50/53
S: (2-)22-36-60-61
613-309-00-61-methyl-3-phenyl-1-piperazine431-180-25271-27-2Xn; R21/22
Xi; R38-41
R52-53		Xn
R: 21/22-38-41-52/53
S: (2-)26-36/37/39-61
613-310-00-1(-)(3 S ,4 R )-4-(4-fluorophenyl)-3-(3,4-methylenedioxy-phenoxymethyl)- N -benzylpiperidine hydrochloride432-360-3105813-13-6Xn; R22
R43
N; R50-53		Xn; N
R: 22-43-50/53
S: (2-)22-24-37-60-61
613-311-00-7methyl-5-nitrophenyl-guanidine435-500-1152460-07-6Xn; R22
Xi; R36
R43
R52-53		Xn
R: 22-36-43-52/53
S: (2-)22-24-26-37-61
613-312-00-22-(4-methyl-2-phenyl-1-piperazinyl)benzenemethanol monohydrochloride420-200-5—Xn; R22
Xi; R41
R43
R52-53		Xn
R: 22-41-43-52/53
S: (2-)22-26-36/37/39-61
613-313-00-82-(4-(4-(3-pyridinyl)-1 H -imidazol-1-yl)butyl)-1 H -isoindole-1,3(2 H )-dione442-780-9173838-67-0R52-53R: 52/53
S: 61
613-314-00-34-decyloxazolidin-2-one;
4-decyl-1,3-oxazolidin-2-one		443-770-77693-82-5N; R50-53N
R: 50/53
S: 22-24-60-61
613-315-00-9tetrapotassium 4-[5-[3-carboxylato-4,5-dihydro-5-oxo-1-(4-sulfonatophenyl)pyrazol-4-ylidene]-3-(piperidinocarbonyl)penta-1,3-dienylidene]-5-hydroxy-1-(4-sulfonatophenyl)pyrazole-3-carboxylate430-390-1—Xn; R20
R52-53		Xn
R: 20-52/53
S: (2-)25-61
613-316-00-4trimethylopropane tri(3-aziridinylpropanoate);
(TAZ)		H257-765-052234-82-9Muta. Cat. 3; R68
Xi; R41
R43		Xn
R: 41-43-68
S: 26-36/37/39-42
615-044-00-14-chlorophenylisocyanate203-176-9104-12-1T+; R26
Xn; R22
Xi; R37/38-41
R42
N; R50-53		T+; N
R: 22-26-37/38-41-42-50/53
S: (1/2-)26-28-36/37/39-45-63-60-61
615-045-00-74,4′-methylene bis(3-chloro-2,6-di-ethylphenylisocyanate)420-530-1—R42/43
R53		Xn
R: 42/43-53
S: (2-)23-24-37-45-61
616-126-00-X1-methyl-4-nitro-3-propyl-1 H -pyrazole-5-carboxamide423-960-6139756-01-7Xn; R22-48/22
R52-53		Xn
R: 22-48/22-52/53
S: (2-)22-36/37-61
616-164-00-7dimoxystrobin (ISO);
( E )-2-(methoxyimino)- N -methyl-2-[α-(2,5-xylyloxy)- o -tolyl]acetamide		—149961-52-4Carc. Cat. 3; R40
Repr. Cat. 3; R63
Xn; R20
N; R50-53		Xn; N
R: 20-40-63-50/53
S: (2-)36/37-46-60-61		C ≥ 25 %: Xn, N; R20-40-63-50/53
5 % ≤ C < 25 %: Xn, N; R40-63-50/53
2,5 % ≤ C < 5 %: Xn, N; R40-50/53
1 % ≤ C < 2,5 %: Xn, N; R40-51/53
0,25 % ≤ C < 1 %: N; R51/53
0,025 % ≤ C < 0,25 %: R52-53
616-165-00-2beflubutamid (ISO);
( RS )- N -benzyl-2-(α,α,α,4-tetrafluoro- m -tolyoxy)butyramide		—113614-08-7N; R50-53N
R: 50/53
S: 60-61		C ≥ 0,25 %: N; R50/53
0,025 % ≤ C < 0,25 %: N; R51/53
0,0025 % ≤ C < 0,025 %: R52/53
616-166-00-8cyazofamid (ISO);
4-chloro-2-cyano- N,N -dimethyl-5- p -tolylimidazole-1-sulfonamide		—120116-88-3N; R50-53N
R: 50/53
S: 60-61		C ≥ 2,5 %: N; R50/53
0,25 % ≤ C < 2,5 %: N; R51-53
0,025 % ≤ C < 0,25 %: R52/53
616-167-00-3N,N -dibutyl-(2,5-dihydro-5-thioxo-1 H -tetrazol-1-yl)acetamide418-290-6168612-06-4Xi; R36
R43		Xi
R: 36-43
S: (2-)24-26-37
616-168-00-91-dimethylcarbamoyl-4-(2-sulfonatoethyl)pyridinium418-440-0136997-71-2R43Xi
R: 43
S: (2-)22-24-37
616-169-00-44-[4-(2,2-dimethyl-propanamido)]phenylazo-3-(2-chloro-5-(2-(3-pentadecylphenoxy)butylamido)anilino)-1-(2,4,6-trichlorophenyl)-2-pyrazoline-5-one420-220-492771-56-7R43
R53		Xi
R: 43-53
S: (2-)24-37-61
616-170-00-X(2 R )-2-amino-2-phenylacetamide420-370-06485-67-2Xi; R36
R43		Xi
R: 36-43
S: (2-)22-26-36/37
616-171-00-52-(para-chlorophenyl)glycineamide420-830-0102333-75-5Xi; R41
R43		Xi
R: 41-43
S: (2-)24-26-37/39
616-172-00-0N -(2,2,6,6-tetramethyl-1-oxylpiperidin-4-yl)acetamide;
(4-acetamido-2,2,6,6-tetramethyl-1-piperidinyl)oxidanyl		423-840-314691-89-5Xn; R22Xn
R: 22
S: (2-)22
616-174-00-12-butyl-1,3-diazaspiro[4.4]non-1-en-4-one hydrochloride424-560-4151257-01-1Xn; R22
Xi; R36		Xn
R: 22-36
S: (2-)22-26
616-175-00-72-(2-hexyldecyloxy)benzamide431-230-3202483-62-3R53R: 53
S: 61
616-176-00-23- N,N -bis(methoxyethyl)aminoacetanilide432-530-724294-01-7Xn; R22
R52-53		Xn
R: 22-52/53
S: (2-)22-24-61
616-177-00-8(3-(4-(2-(butyl-(4-methylphenylsulfonyl)amino)phenylthio)-5-oxo-1-(2,4,6-trichlorophenyl)-4,5-dihydro-1 H -pyrazole-3-ylamino)-4-chlorophenyl)tetradecanamide;
N -[3-({4-[(2-{butyl[(4-methylphenyl)sulfonyl]amino}phenyl)thio]-5-oxo-1-(2,4,6-trichlorophenyl)-4,5-dihydro-1 H -pyrazol-3-yl}amino)-4-chlorophenyl]tetradecanamide		432-970-1217324-98-6R53R: 53
S: 61
616-178-00-3N -(5-(bis(2-methoxyethyl)amino)-2-((2-cyano-4,6-dinitrophenyl)-azo)phenyl)acetamide434-500-952583-35-4R53R: 53
S: 22-61
616-179-00-92-chloro- N -(4-methylphenyl)acetamide435-170-916634-82-5Xi; R41
R43
N; R50-53		Xi; N
R: 41-43-50/53
S: (2-)22-26-36/37/39-60-61
616-180-00-4N,N -(dimethylamino)thioacetamide hydrochloride435-470-127366-72-9Repr. Cat. 2; R61
N; R50-53		T; N
R: 61-50/53
S: 53-45-60-61
616-181-00-X4′-methyldodecane-1-sulfonanilide435-490-917417-32-2N; R50-53N
R: 50/53
S: 60-61
616-182-00-5N′ -(1,3-dimethylbutylidene)-3-hydroxy-2-naphthohydrazide435-860-1214417-91-1R43
N; R51-53		Xi; N
R: 43-51/53
S: (2-)24-37-61
616-183-00-0N -dodecyl-4-methoxybenzamide442-340-61854-15-5R53R: 53
S: 61
616-184-00-63-methyl- N -(5,8,13,14-tetrahydro-5,8,14-trioxonaphth[2,3-c]acridin-6-yl)benzamide442-560-2105043-55-8R53R: 53
S: 61
616-186-00-7N,N′ -(2-chloro-1,4-phenylene)bis(3-oxobutaneamide)443-010-453641-10-4R52-53R: 52/53
S: 61
616-188-00-82-(5,5-dimethyl-2,4-dioxooxazolidin-3-yl)-4,4-dimethyl-3-oxo- N -(2-methoxy-5-octadecanoylaminophenyl)pentanoic acid amide443-980-9221215-20-9R43
R53		Xi
R: 43-53
S: (2-)24-37-61
616-189-00-3N -[5-(bis-(2-methoxy-ethyl)-amino]-2-(6-bromo-2-methyl-1,3-dioxo-2,3-dihydro-1 H -isoindol-5-ylazo)-phenyl]acetamide444-780-4452962-97-9R53R: 53
S: 61
616-190-00-9N -decyl-4-nitrobenzamide445-880-064026-19-3R53R: 53
S: 61
616-191-00-42-ethyl- N -methyl- N -(3-methylphenyl)butanamide446-190-2406488-30-0Xn; R22
Xi; R36/38
R43
N; R51-53		Xn; N
R: 22-36/38-43-51/53
S: (2-)24-26-37-61
616-192-00-X2-[2-(3-butoxypropyl)-1,1-dioxo-1,2,4-benzothiadiazin-3-yl]-5′- tert -butyl-2-(5,5-dimethyl-2,4-dioxo-1,3-oxazolidin-3-yl)-2′-[(2-ethylhexyl)thio]acetanilide448-060-0727678-39-9R53R: 53
S: 61
616-193-00-5N -[2-(2-butyl-4,6-dicyano-1,3-dioxo-2,3-dihydro-1 H -isoindol-5-ylazo)-5-diethylamino-phenyl]acetamide449-940-7368450-39-9R53R: 53
S: 61
616-194-00-02,2-diethoxy- N,N -dimethylacetamide449-950-134640-92-1Xi; R36Xi
R: 36
S: (2-)26
616-196-00-1disodium salt of 1-hydroxy-4-(β-(4-(1-hydroxy-3,6-disulfo-8-acetylamino-2-naphthylazo)phenoxy)ethoxy)- N -dodecyl-2-naphthamide419-990-4—N; R50-53N
R: 50/53
S: 60-61
616-197-00-7mixture of: potassium N -[3-(dimethyloxidoamino)propyl]-1,1,2,2,3,3,4,4,5,5,6,6,7,7,8,8,8-heptadecafluorooctane sulfonamidate;
N -[3-(dimethyloxidoamino)propyl]-1,1,2,2,3,3,4,4,5,5,6,6,7,7,8,8,8-heptadecafluorooctane sulfonamide		422-500-1—Xn; R48/22Xn
R: 48/22
S: (2-)22-36
616-198-00-21,3-bis[12-hydroxy-octadecamide- N -methylene]-benzene423-300-7—R43
R53		Xi
R: 43-53
S: (2-)24-37-61
616-200-00-1mixture of: N,N′ -ethane-1,2-diylbis(hexanamide);
12-hydroxy- N -[2-[(1-oxyhexyl)amino]ethyl]octadecanamide;
N,N′ -ethane-1,2-diylbis(12-hydroxyoctadecanamide)		432-430-3—R43
R53		Xi
R: 43-53
S: (2-)24-37-61
616-201-00-712-hydroxyoctadecanoic acid, reaction products with 1,3-benzenedimethanamine and hexamethylenediamine432-840-2220926-97-6Xn; R20
R53		Xn
R: 20-53
S: (2-)22-61
616-202-00-2mixture of: 2,2′-[(3,3′-dichloro[1,1′-biphenyl]-4,4′-diyl)bis(azo)]bis[ N -(2,4-dimethylphenyl)]-3-oxo-butanamide;
2-[[3,3′-dichloro-4′-[[1[[(2,4-dimethylphenyl)amino]carbonyl]-2-oxopropyl]azo][1,1′-biphenyl]-4-yl]azo]- N -(2-methylphenyl)-3-oxo-butanamide;
2-[[3,3′-dichloro-4′-[[1[[(2,4-dimethylphenyl)amino]carbonyl]-2-oxopropyl]azo][1,1′-biphenyl]-4-yl]azo]- N -(2-carboxylphenyl)-3-oxo-butanamide		434-330-5—Carc. Cat. 3; R40
R43
R53		Xn
R: 40-43-53
S: (2-)36/37-61
616-203-00-8mixture of: N -[5-[bis-(2-methoxyethyl)amino]-2-(2-butyl-4,6-dicyano-1,3-dioxo-2,3-dihydro-1 H -isoindol-5-yl-azo)phenyl]acetamide;
N -[2-(2-butyl-4,6-dicyano-1,3-dioxo-2,3-dihydro-1 H -isoindol-5-ylazo)5-diethylaminophenyl]acetamide		442-280-0—R53R: 53
S: 61
616-204-00-3N,N″ -(methylenedi-4,1-phenylene)bis[ N′ -octylurea]451-060-3122886-55-9R53R: 53
S: 61
617-022-00-7mixture of: 1,2-dimethylpropylidene dihydroperoxide;
dimethyl 1,2-benzenedicarboxylate		442-480-8—O; R7
Xn; R22
C; R34
R43
N; R51-53		O; C; N
R: 7-22-34-43-51/53
S: (1/2-)3/7-14-26-36/37/39-45-50-61
647-017-00-5laccase420-150-480498-15-3R42Xn
R: 42
S: (2-)23-45

The entries in Annex I with the following Index numbers are deleted:

024-004-01-4, 603-037-01-3, 603-155-00-8, and 611-084-00-9.

Footnotes

  1. . ↩ ↩2

Continue your research in ChatGPT or Claude

Connect Omnilex to search the legal corpus from your AI assistant.